0001047469-16-012899.txt : 20160505 0001047469-16-012899.hdr.sgml : 20160505 20160505080924 ACCESSION NUMBER: 0001047469-16-012899 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 41 CONFORMED PERIOD OF REPORT: 20160331 FILED AS OF DATE: 20160505 DATE AS OF CHANGE: 20160505 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Inovalon Holdings, Inc. CENTRAL INDEX KEY: 0001619954 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 471830316 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36841 FILM NUMBER: 161621659 BUSINESS ADDRESS: STREET 1: 4321 COLLINGTON ROAD CITY: BOWIE STATE: MD ZIP: 20716 BUSINESS PHONE: 301-809-4000 MAIL ADDRESS: STREET 1: 4321 COLLINGTON ROAD CITY: BOWIE STATE: MD ZIP: 20716 10-Q 1 a2228514z10-q.htm 10-Q

Use these links to rapidly review the document
TABLE OF CONTENTS

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 10-Q


(Mark One)
ý		QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2016
or
o		TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to

Commission File Number 001-36841

INOVALON HOLDINGS, INC.
(Exact name of registrant as specified in its charter)


Delaware (State or other jurisdiction of incorporation or organization)		47-1830316 (I.R.S. Employer Identification No.)
4321 Collington Road, Bowie, Maryland (Address of principal executive offices)		20716 (Zip Code)

(301) 809-4000
Registrant's telephone number, including area code

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ý No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.


Large accelerated filer o		Accelerated filer o		Non-accelerated filer ý (Do not check if a smaller reporting company)		Smaller reporting company o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes o No ý

As of April 30, 2016, the registrant had 66,905,308 shares of Class A common stock outstanding and 85,437,106 shares of Class B common stock outstanding.

Table of Contents

INOVALON HOLDINGS, INC.

FORM 10-Q
FOR THE QUARTER ENDED MARCH 31, 2016

TABLE OF CONTENTS



PART I—FINANCIAL INFORMATION
Item 1.	Condensed Consolidated Financial Statements (unaudited)	1
	Condensed Consolidated Balance Sheets as of March 31, 2016 and December 31, 2015	1
	Condensed Consolidated Statements of Income for the three months ended March 31, 2016 and 2015	2
	Condensed Consolidated Statements of Comprehensive Income for the three months ended March 31, 2016 and 2015	3
	Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2016 and 2015	4
	Notes to Condensed Consolidated Financial Statements	5
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	12
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	24
Item 4.	Controls and Procedures	25
PART II—OTHER INFORMATION
Item 1.	Legal Proceedings	26
Item 1A.	Risk Factors	26
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	26
Item 3.	Defaults Upon Senior Securities	27
Item 4.	Mine Safety Disclosures	27
Item 5.	Other Information	27
Item 6.	Exhibits	27
SIGNATURES		29

Table of Contents

PART I—FINANCIAL INFORMATION

Item 1. Condensed Consolidated Financial Statements

INOVALON HOLDINGS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and par value amounts)

	March 31, 2016		December 31, 2015

	(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	126,885	$	114,034
Short-term investments		611,598		614,130
Accounts receivable (net of allowances of $1,320 and $1,022 at March 31, 2016 and December 31, 2015, respectively)		73,177		81,305
Prepaid expenses and other current assets		21,217		16,162
Income tax receivable		17,251		18,377

Total current assets		850,128		844,008
Non-current assets:
Property, equipment and capitalized software, net		65,278		65,031
Goodwill		137,733		137,733
Intangible assets, net		60,028		61,855
Other assets		3,940		4,250

Total assets	$	1,117,107	$	1,112,877



LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable	$	17,716	$	21,136
Accrued compensation		10,281		13,538
Other current liabilities		14,168		11,444
Deferred revenue		7,044		5,507
Deferred rent		843		797
Credit facilities		18,750		15,000
Capital lease obligation		109		109

Total current liabilities		68,911		67,531
Non-current liabilities:
Credit facilities, less current portion		258,750		266,250
Capital lease obligation, less current portion		309		296
Deferred rent		2,251		2,446
Deferred income taxes		36,275		37,198

Total liabilities		366,496		373,721

Commitments and contingencies (Note 5)
Stockholders' equity:
Common stock, $0.000005 par value, 900,000,000 shares authorized, zero shares issued and outstanding at each of March 31, 2016 and December 31, 2015, respectively		—		—
Class A common stock, $0.000005 par value, 750,000,000 shares authorized, 66,129,038 and 53,482,669 shares issued and outstanding at March 31, 2016 and December 31, 2015, respectively		—		—
Class B common stock, $0.000005 par value, 150,000,000 shares authorized, 86,235,350 and 98,230,363 shares issued and outstanding at March 31, 2016 and December 31, 2015, respectively		1		1
Preferred stock, $0.0001 par value, 100,000,000 shares authorized, zero shares issued and outstanding at March 31, 2016 and December 31, 2015, respectively		—		—
Additional paid-in-capital		499,899		493,197
Retained earnings		249,905		247,540
Other comprehensive income (loss)		806		(1,582	)

Total stockholders' equity		750,611		739,156

Total liabilities and stockholders' equity	$	1,117,107	$	1,112,877

See notes to condensed consolidated financial statements.

Table of Contents

INOVALON HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited, in thousands, except per-share amounts)

	Three Months Ended March 31,

	2016			2015
Revenue	$	102,657		$	93,633
Expenses:
Cost of revenue(1)		41,923			31,851
Sales and marketing(1)		6,559			1,850
Research and development(1)		5,932			5,411
General and administrative(1)		36,552			24,258
Depreciation and amortization		8,394			4,915

Total operating expenses		99,360			68,285

Income from operations		3,297			25,348

Other income and (expenses):
Realized losses on short-term investments		(4	)		—
Gain on disposal of equipment		534			—
Interest income		1,442			8
Interest expense		(1,259	)		(1,103	)

Income before taxes		4,010			24,253
Provision for income taxes		1,645			10,494

Net income	$	2,365		$	13,759



Net income attributable to common stockholders, basic and diluted	$	2,356		$	13,759



Net income per share attributable to common stockholders, basic and diluted:
Basic net income per share	$	0.02		$	0.10



Diluted net income per share	$	0.02		$	0.10



Weighted average shares of common stock outstanding:
Basic		151,282			135,331



Diluted		152,355			138,902

(1): Includes stock-based compensation expense as follows:


Cost of revenue	$	119	$	28
Sales and marketing		154		15
Research and development		242		362
General and administrative		1,577		1,367

Total stock-based compensation expense	$	2,092	$	1,772

See notes to condensed consolidated financial statements.

Table of Contents

INOVALON HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited, in thousands)

	Three Months Ended March 31,

	2016		2015
Net income	$	2,365	$	13,759
Other comprehensive income:
Realized losses on short-term investments reclassified from accumulated other comprehensive income, net of tax of $1		3		—
Net change in unrealized gains and (losses) on available-for-sale investments, net of tax of $560		2,385		—

Comprehensive income	$	4,753	$	13,759

See notes to condensed consolidated financial statements.

Table of Contents

INOVALON HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited, in thousands)

	Three Months Ended March 31,

	2016			2015
Cash flows from operating activities:
Net income	$	2,365		$	13,759
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation expense		2,092			1,772
Depreciation		6,567			4,373
Amortization of intangibles		1,827			542
Amortization of premiums on short-term investments		871			—
Realized losses on short-term investments		4			—
Tax payments for equity award issuances		88			—
Deferred income taxes		(1,252	)		(493	)
Excess tax benefits from stock-based compensation		(911	)		—
Loss on disposal of long-lived assets		—			4
Gain on disposal of equipment		(534	)		—
Changes in assets and liabilities:
Accounts receivable		8,128			(21,703	)
Prepaid expenses and other current assets		(5,054	)		277
Income taxes receivable		2,037			6,797
Other assets		78			(171	)
Accounts payable		(2,194	)		(1,685	)
Accrued compensation		(3,877	)		(6,368	)
Other liabilities		2,676			655
Deferred rent		(149	)		(109	)
Deferred revenue		1,537			613
Income taxes payable		—			2,554

Net cash provided by operating activities		14,299			817

Cash flows from investing activities:
Purchases of short-term investments		(80,065	)
Sales and maturities of short-term investments		84,671
Purchases of property and equipment		(4,053	)		(1,338	)
Investment in capitalized software		(2,790	)		(5,158	)

Net cash used in investing activities		(2,237	)		(6,496	)

Cash flows from financing activities:
Proceeds from issuance of common stock, net of underwriters' discount		—			362,082
Proceeds from issuance of treasury stock, net of underwriters' discount		—			282,172
Payment of offering costs		—			(3,002	)
Repayment of credit facility borrowings		(3,750	)		(5,000	)
Proceeds from exercise of stock options		3,841			—
Capital lease obligations paid		(31	)		(26	)
Tax payments for equity award issuances		(182	)		—
Excess tax benefits from stock-based compensation		911			—

Net cash provided by financing activities		789			636,226

Increase in cash and cash equivalents		12,851			630,547
Cash and cash equivalents, beginning of period		114,034			162,567

Cash and cash equivalents, end of period	$	126,885		$	793,114



Supplementary cash flow disclosure:
Cash paid during the period for:
Income taxes, net of refunds	$	861		$	1,583
Interest		1,195			1,076
Non-cash investing activities:
Accounts payable for purchases of and investment in property, equipment and capitalized software		933			1,557
Accrued compensation for investment in capitalized software		53			464
Offering costs not yet paid		—			2,180

See notes to condensed consolidated financial statements.

Table of Contents

INOVALON HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1. BASIS OF PRESENTATION

The accompanying unaudited condensed consolidated financial statements have been prepared by Inovalon Holdings, Inc. (the "Company") in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial reporting and as required by Rule 10-01 of Regulation S-X. Accordingly, the unaudited condensed consolidated financial statements may not include all of the information and notes required by GAAP for audited financial statements. In the opinion of the Company's management, the accompanying unaudited condensed consolidated financial statements contain all adjustments, consisting of items of a normal and recurring nature, necessary to present fairly the Company's financial position as of March 31, 2016 and the results of operations, comprehensive income and cash flows for the three month periods ended March 31, 2016 and 2015. The results of operations for the three month period ended March 31, 2016 are not necessarily indicative of the results to be expected for the full year. The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities, disclosures of contingent assets and liabilities as of the date of the financial statements, and the reported amounts of revenue and expenses during the reported period. Actual results could differ from management's estimates, and such differences could be material to the Company's consolidated financial position and results of operations.

The accompanying condensed consolidated financial statements include the accounts of Inovalon Holdings, Inc. and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.

The Company's management considers events or transactions that occur after the balance sheet date but before the financial statements are issued to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure. Subsequent events have been evaluated through the date of issuance of these financial statements.

Recently Issued Accounting Standards

There have been no developments to recently issued accounting standards, including the expected dates of adoption and estimated effects on the Company's consolidated financial statements and note disclosures, from those disclosed in the Company's 2015 Annual Report on Form 10-K, except for the following:

In February 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update No. 2016-02, Leases (Topic 842) ("ASU 2016-02"). ASU 2016-02 requires the identification of arrangements that should be accounted for as leases by lessees. This guidance is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. In general, for lease arrangements exceeding a twelve month term, these arrangements will be recognized as assets and liabilities on the balance sheet of the lessee. Under ASU 2016-02, a right-of-use asset and lease obligation will be recorded for all leases, whether operating or financing, while the income statement will reflect lease expense for operating leases and amortization/interest expense for financing leases. The balance sheet amount recorded for existing leases at the date of adoption of ASU 2016-02 will be calculated using the applicable incremental borrowing rate at the date of adoption. In addition, ASU 2016-02 requires the use of the modified retrospective method, which will require adjustment to all comparative periods presented in the

Table of Contents

INOVALON HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

1. BASIS OF PRESENTATION (Continued)

consolidated financial statements. The Company is currently assessing the impact that adopting this new accounting standard will have on its consolidated financial statements and note disclosures.

In March 2016, the FASB issued Accounting Standards Update No. 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net) ("ASU 2016-08"). This guidance is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017. ASU 2016-08 clarifies the implementation guidance on principal versus agent considerations. The guidance includes indicators to assist an entity in determining whether it controls a specified good or service before it is transferred to the customers. The Company is currently assessing the impact that adopting this new accounting standard will have on its consolidated financial statements and note disclosures.

In March 2016, the FASB issued Accounting Standards Update No. 2016-09, Compensation—Stock Compensation (Topic 718) ("ASU 2016-09"). This guidance is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016, with early adoption permitted. ASU 2016-09 identifies areas for simplification involving several aspects of accounting for share-based payment transactions, including income tax consequences, classification of awards as either equity or liabilities, an option to recognize gross stock compensation expense with actual forfeitures recognized as they occur, as well as certain classifications on the statement of cash flows. The Company is currently assessing the impact that adopting this new accounting standard will have on its consolidated financial statements and note disclosures. The adoption of this new accounting standard could have a material impact on the Company's consolidated financial statements.

2. NET INCOME PER SHARE (in thousands, except per share amounts)

Holders of all outstanding classes of common stock participate ratably in earnings on an identical per share basis as if all shares were a single class. Basic earnings per share ("EPS") is computed by dividing net income by the weighted average number of shares of common stock, Class A common stock and Class B common stock outstanding during the period. Diluted EPS is computed by dividing net income by the sum of the weighted average number of shares of common stock outstanding and potentially dilutive securities outstanding during the period under the treasury stock method. Potentially dilutive securities include stock options and restricted stock units ("RSUs") and restricted stock awards ("RSAs"). Under the treasury stock method, dilutive securities are assumed to be exercised at the beginning of the periods and as if funds obtained thereby were used to purchase common stock at the average market price during the period. Securities are excluded from the computations of diluted earnings per share if their effect would be anti-dilutive to EPS.

The Company has issued restricted share awards of Class A common stock (RSAs) under the 2015 Omnibus Incentive Plan. The Company considers issued and unvested RSAs to be participating securities as the holders of these RSAs have a non-forfeitable right to dividends in the event of the Company's declaration of a dividend on shares of Class A and Class B common stock. Subsequent to the issuance of the participating securities, the Company applied the two-class method required in calculating net income per share of Class A and Class B common stock. Under the two-class method, net income attributable to common stockholders is determined by allocating undistributed earnings, calculated as net income, less earnings attributable to participating securities. The net income per share attributable to common stockholders is allocated based on the contractual participation rights of the

Table of Contents

INOVALON HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

2. NET INCOME PER SHARE (in thousands, except per share amounts) (Continued)

Class A common stock and Class B common stock as if the income for the period has been distributed. As the liquidation and dividend rights are identical for both classes of common stock, the net income attributable to common stockholders is allocated on a proportionate basis.

The following table reconciles the weighted average shares outstanding for basic and diluted EPS for the periods indicated:

	Three Months Ended March 31,

	2016			2015
*Basic*
Numerator:
Net income	$	2,365		$	13,759
Undistributed earnings allocated to participating securities		(9	)		—

Net income attributable to common stockholders—basic	$	2,356		$	13,759



Denominator:
Weighted average shares used in computing net income per share attributable to common stockholders—basic		151,282			135,331

Net income per share attributable to common stockholders—basic	$	0.02		$	0.10



*Diluted*
Numerator:
Net income attributable to common stockholders—diluted	$	2,356		$	13,759



Denominator:
Number of shares used for basic EPS computation		151,282			135,331
Effect of dilutive securities		1,073			3,571

Weighted average shares used in computing net income per share attributable to common stockholders—diluted		152,355			138,902

Net income per share attributable to common stockholders—diluted	$	0.02		$	0.10

The computation of diluted EPS does not include certain unvested awards, for the three months ended March 31, 2016 and 2015, because their inclusion would have an anti-dilutive effect on EPS. The awards excluded because of their anti-dilutive effect are as follows:

	Three Months Ended March 31,

	2016		2015
Awards excluded from the computation of diluted net income per share because their inclusion would have been anti-dilutive		110		23

Table of Contents

INOVALON HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

3. SHORT-TERM INVESTMENTS (in thousands)

As of March 31, 2016, short-term investments consisted of the following:

	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Estimated Fair Value

Available-for-sale securities:
Corporate notes and bonds	$	407,461	$	620	$	(528	)	$	407,553
U.S. agency obligations		97,562		43		(13	)		97,592
U.S. treasury securities		70,291		76		(27	)		70,340
Commercial paper		29,798		66		(6	)		29,858
Certificates of deposit		6,251		4		—			6,255

Total available-for-sale securities	$	611,363	$	809	$	(574	)	$	611,598

As of December 31, 2015, short-term investments consisted of the following:

	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Estimated Fair Value

Available-for-sale securities:
Corporate notes and bonds	$	390,185	$	12	$	(2,321	)	$	387,876
U.S. agency obligations		121,521		11		(203	)		121,329
U.S. treasury securities		60,362		2		(179	)		60,185
Commercial paper		36,849		—		(28	)		36,821
Certificates of deposit		7,928		—		(9	)		7,919

Total available-for-sale securities	$	616,845	$	25	$	(2,740	)	$	614,130

The following table summarizes the estimated fair value of our short-term investments, designated as available-for-sale and classified by the contractual maturity date of the securities as of the dates shown:

	March 31, 2016		December 31, 2015

Due in one year or less	$	217,876	$	206,679
Due after one year through three years		393,722		407,451

Total	$	611,598	$	614,130

The Company has certain available-for-sale securities in a gross unrealized loss position, all of which have been in such position for less than 12 months. The Company reviews its debt securities classified as short-term investments on a regular basis to evaluate whether or not any security has experienced an other-than-temporary decline in fair value. The Company considers factors such as the length of time and extent to which the market value has been less than the cost, the financial position and near-term prospects of the issuer and the Company's intent to sell, or whether it is more likely than not the Company will be required to sell the investment before recovery of the investment's amortized-cost basis. If the Company determines that an other-than-temporary decline exists, or if write

Table of Contents

INOVALON HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

3. SHORT-TERM INVESTMENTS (in thousands) (Continued)

downs related to credit losses are necessary, in one of these securities, the unrealized losses attributable to the respective investment would be reclassified to realized losses on short-term investments within the statement of operations. There were no impairments considered other-than-temporary as of March 31, 2016.

The following table shows the fair values and the gross unrealized losses of available-for-sale securities that have been in a gross unrealized loss position for less than 12 months, aggregated by investment category as of March 31, 2016:

	Estimated Fair Value		Gross Unrealized Losses

Corporate notes and bonds	$	257,125	$	(528	)
U.S. agency obligations		30,585		(13	)
U.S. treasury securities		50,977		(27	)
Commercial paper		12,475		(6	)
Certificates of deposit		961		—

	$	352,123	$	(574	)

4. FAIR VALUE MEASUREMENTS (in thousands)

The following table presents the fair value hierarchy for financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2016:

	Level 1		Level 2		Level 3			Total

Cash Equivalents:
Money market funds	$	19,298	$	—	$	—		$	19,298
Short-term investments:
Corporate notes and bonds		—		407,553		—			407,553
U.S. agency obligations		—		97,592		—			97,592
U.S. treasury securities		—		70,340		—			70,340
Commercial paper		—		29,858		—			29,858
Certificates of deposit		—		6,255		—			6,255
Other Current Liabilities:
Contingent consideration		—		—		(2,300	)		(2,300	)

Total	$	19,298	$	611,598	$	(2,300	)	$	628,596

Table of Contents

INOVALON HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

4. FAIR VALUE MEASUREMENTS (in thousands) (Continued)

The following table presents the fair value hierarchy for financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2015:

	Level 1		Level 2		Level 3			Total

Cash Equivalents:
Money market funds	$	2,521	$	—	$	—		$	2,521
Short-term investments:
Corporate notes and bonds		—		387,876		—			387,876
U.S. agency obligations		—		121,329		—			121,329
U.S. treasury securities		—		60,185		—			60,185
Commercial paper		—		36,821		—			36,821
Certificates of deposit		—		7,919		—			7,919
Other Current Liabilities:
Contingent consideration		—		—		(2,300	)		(2,300	)

Total	$	2,521	$	614,130	$	(2,300	)	$	614,351

The Company determines the fair value of its security holdings based on pricing from its pricing vendors. The valuation techniques used to measure the fair value of financial instruments having Level 2 inputs were derived from non-binding consensus prices that are corroborated by observable market data or quoted market prices for similar instruments. Such market prices may be quoted prices in active markets for identical assets (Level 1 inputs) or pricing determined using inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs). The Company performs procedures to ensure that appropriate fair values are recorded such as comparing prices obtained from other sources.

On September 1, 2015, the Company recorded contingent consideration at its fair value in conjunction with the acquisition of Avalere Health, Inc. The Company determines fair value of its contingent consideration, using Level 3 inputs under the fair value hierarchy, consisting of information provided by observing certain operating metrics along with management's own assumptions. The Company adjusts the estimated fair value of its contingent consideration quarterly, if there is a change in the aforementioned factors considered in determining the fair value of the contingent consideration. The change in value, if any, is reflected in the Company's statements of operations as gain (loss) from contingent consideration valuation as a component of general and administrative expenses. For the three months ended March 31, 2016 there was no change in the fair value of the contingent consideration.

5. COMMITMENTS AND CONTINGENCIES (in thousands)

Litigation—From time to time the Company is involved in various litigation matters arising out of the normal course of business. The Company consults with legal counsel on those issues related to litigation and seeks input from other experts and advisors with respect to such matters. Estimating the probable losses or a range of probable losses resulting from litigation, government actions and other legal proceedings is inherently difficult and requires an extensive degree of judgment, particularly where the matters involve indeterminate claims for monetary damages, may involve discretionary amounts, present novel legal theories, are in the early stages of the proceedings, or are subject to

Table of Contents

INOVALON HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(Unaudited)

5. COMMITMENTS AND CONTINGENCIES (in thousands) (Continued)

appeal. Whether any losses, damages or remedies ultimately resulting from such matters could reasonably have a material effect on the Company's business, financial condition, results of operations, or cash flows will depend on a number of variables, including, for example, the timing and amount of such losses or damages (if any) and the structure and type of any such remedies. The Company's management does not presently expect any litigation matters to have a material adverse impact on the condensed consolidated financial statements of the Company.

Table of Contents

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis should be read in conjunction with our condensed consolidated financial statements and the related notes included elsewhere in this Quarterly Report on Form 10-Q and with our audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2015, as filed with the Securities and Exchange Commission (the "SEC") on February 26, 2016. Unless we otherwise indicate or the context requires, references to the "Company," "Inovalon," "we," "our," and "us" refer to Inovalon Holdings, Inc. and its consolidated subsidiaries.

Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). All statements contained in this Quarterly Report other than statements of historical fact, including but not limited to statements regarding our future results of operations and financial position, our business strategy and plans, market growth, and our objectives for future operations, are forward-looking statements. The words "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect," and similar expressions are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives and financial needs. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the future events and trends discussed in this Quarterly Report may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.

Factors that may cause actual results to differ from expected results include, among others:

•: our future financial performance, including our ability to continue and manage our growth;
•: our ability to retain our client base;
•: the effect of the concentration of our revenue among our top clients;
•: our ability to innovate and adapt our platforms and toolsets;
•: the effects of regulations applicable to us, including regulations relating to data protection and data privacy;
•: the effects of consolidation in the managed care industry;
•: the ability to successfully integrate our acquisitions and the ability of the acquired business to perform as expected;
•: the successful implementation and adoption of new platforms, products and solutions;
•: the effects of changes in tax legislation for jurisdictions within which we operate;
•: the ability to protect the privacy of our clients' data and prevent security breaches;
•: the continuation of our share repurchase program;
•: the effect of competition on our business; and

Table of Contents

•: the efficacy of our platforms and toolsets.

Forward-looking statements are only current predictions and are subject to known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from those anticipated by such statements. These factors include, among other factors, those set forth in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015, under the heading Part I, Item 1A, "Risk Factors".

You should not rely upon forward-looking statements as predictions of future events. The events and circumstances reflected in the forward-looking statements may not be achieved or occur. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. We are under no duty to, and we disclaim any obligation to, update any of these forward- looking statements after the date of this Quarterly Report or to conform these statements to actual results or revised expectations.

Overview

We are a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape. We deliver value to our clients by turning data into insights and those insights into action. Currently, our clients include health plans, hospitals, physicians, patients, pharmaceutical companies and researchers.

Our large proprietary datasets, advanced integration technologies, sophisticated predictive analytics, and deep subject matter expertise allow us to provide seamless, end-to-end platforms that bring the benefits of big data and large-scale analytics to the point of care. Our data analytics platforms identify gaps in care, quality, data integrity, and financial performance in our clients' datasets. Our data-driven intervention platforms enable our clients to take the insights derived from the analytics and implement unique, patient-level solutions, drive impact and enhance patient engagement. Through these capabilities, and those of our subsidiary Avalere, which offers data-driven advisory services and business intelligence to more than 200 pharmaceutical and life sciences enterprises, as well as an extensive array of client relationships with payors, providers and research institutions, we are able to drive high-value impact, improving quality and economics for health plans, accountable care organizations ("ACOs"), hospitals, physicians, consumers and pharma/life-sciences researchers.

We generate the substantial majority of our revenue through the sale or subscription licensing of our cloud-based data analytics and data-driven intervention platform services.

For the three months ended March 31, 2016, we generated revenue of $102.7 million from the sale of our services compared to $93.6 million for the three months ended March 31, 2015. Given the scope of our market opportunity, we have historically invested more each year on innovation and infrastructure, in order to support our growth.

Recent Developments

On May 4, 2016 we announced that our Board of Directors has authorized a program to repurchase up to $100 million of Inovalon's Class A common stock through December 31, 2016. Repurchases under the Company's share repurchase program will be made in open-market or privately negotiated transactions in compliance with Rule 10b-18 of the Securities Exchange Act of 1934, as amended, subject to market conditions, applicable legal requirements, and other relevant factors. The share repurchase program does not obligate us to acquire any particular amount of Class A common stock.

Table of Contents

Quarterly Key Metrics

We review certain metrics quarterly, including the key metrics shown in the table below. We believe that these metrics are indicative of our overall level of analytical activity and the underlying growth in our business.

	As of March 31,

	2016		2015
	(in thousands)
MORE² Registry® dataset metrics(1)
Unique patient count(2)		132,361		121,918
Medical event count(3)		11,300,216		9,656,623
Trailing 12 month Patient Analytics Months (PAM)(1)(4)		22,125,006		17,829,812

(1): MORE² Registry® dataset metrics and Trailing 12 month PAM, each of which is presented in the table, are key operating metrics that management uses to assess our level of operational activity. While we believe that each of these metrics is indicative of our overall level of analytical activity and the underlying growth in our business, increases or decreases in these metrics do not necessarily correlate to proportional increases or decreases in revenue, or net income. For instance, although increased levels of analytical activity historically have corresponded to increases in revenue over the long term, differences in fees charged for different analytical packages exist and differences in how analytics trigger the applicability of our data-driven intervention platforms may result in increases in analytical activity that do not result in proportional increases in revenue, or net income (and vice versa). Accordingly, while we believe the presentation of these operating metrics is helpful to investors in understanding our business; these metrics have limitations and should not be considered as substitutes for analysis of our financial results reported under GAAP. In addition, we believe that other companies, including companies in our industry, do not present similar operating metrics and that there is no commonly accepted method of calculating these metrics, which may reduce their usefulness as comparative measures.
(2): Unique patient count is defined as each unique, longitudinally matched, de-identified natural person represented in our MORE² Registry® as of the end of the period presented.
(3): Medical event count is defined as the total number of discrete medical events as of the end of the period presented (for example, a discrete medical event typically results from the presentation of a patient to a physician for the diagnosis of diabetes and congestive heart failure in a single visit, the presentation of a patient to an emergency department for chest pain, etc.).
(4): PAM is defined as the sum of the analytical processes performed on each respective patient within patient populations covered by clients under contract. As used in the metric, an "analytical process" is a distinct set of data calculations undertaken by us which is initiated and completed by our analytical platform to examine a specific question such as whether a patient is believed to have a condition such as diabetes, or worsening of the disease, during a specific time period.

Trends and Factors Affecting Our Future Performance

A number of factors influence our growth and performance. We see many of these factors as being more quantitatively driven, such as the rate of growth of the underlying data counts within our datasets, the ongoing investment in innovation, the number of statement of work contracts maintained by us, and

Table of Contents

our level of analytical activity. Additionally, there are several factors that influence our growth and performance that are less quantitatively driven, including seasonality, macro-economic forces, and trends within healthcare (such as payment models, incentivization, and regulatory oversight), that can be driven by changes in federal and state laws and regulations, as well as private sector market forces.

Growth of Datasets. Healthcare costs in the United States have been increasing significantly for many years. This rise in healthcare costs has driven a broad transition from consumption-based payment models to quality and value-based payment models across the healthcare landscape. As a result, the specific disease and comorbidity status, clinical and quality outcomes, resource utilization, and care details of the individual patient have become increasingly relevant to the various constituents across the healthcare delivery system. Concurrently, the count and complexity of diseases, diagnostics, and treatments—as well as payment models and regulatory oversight requirements—have soared. In this setting, granular data has become critical to determining and improving quality and financial performance in healthcare. Our MORE² Registry® is our largest principal dataset and serves as a proxy for our general growth of datasets within Inovalon. The growth of our datasets that inform our analytical capabilities and comparative analytics is a key aspect of our provision of value to our clients and is indicative of our overall growth and capabilities.

Innovation and Platform Development. Our business model is based upon our ability to deliver value to our clients through the combination of advanced, cloud-based data analytics and data-driven intervention platforms focused on the achievement of meaningful and measureable improvements in clinical quality outcomes and financial performance in healthcare. Our ability to deliver this value is dependent in part on our ability to continue to innovate, design new capabilities, and bring these capabilities to market in an enterprise scale. Our continued ability to innovate our platform and bring differentiated capabilities to market is an important aspect of our business success. Our investment in innovation includes costs for research and development, capitalized software development, and capital expenditures related to hardware and software platforms on which our data analytics and data-driven interventions capabilities are deployed as summarized below (in thousands, except percentages).

	Three Months Ended March 31,

	2016			2015
Investment in Innovation:
Research and development(1)	$	5,932		$	5,411
Capitalized software development(2)		5,300			4,508
Research and development infrastructure investments(3)		379			100

Total investment in innovation	$	11,611		$	10,019



As a percentage of revenue
Research and development(1)		6	%		6	%
Capitalized software development(2)		5	%		5	%
Research and development infrastructure investments(3)		—	%		—	%

Total investment in innovation		11	%		11	%

(1): Research and development primarily includes employee costs related to the development and enhancement of our service offerings.
(2): Capitalized software development includes capitalized costs incurred to develop and enhance functionality for our data analytics and data-driven intervention platforms.
(3): Research and development infrastructure investments include strategic capital expenditures related to hardware and software platforms under development or enhancement.

Table of Contents

Client and Analytical Process Count Growth. Our business is generally driven by the number of underlying patients for which our analytics and data-driven intervention platforms are being utilized. As such, we track the number of analytical processes that we run on patients each month in fulfillment of our client contracts, as totaled for the trailing 12 months. This metric is referred to as the Trailing 12 month Patient Analytical Months, or PAM. We believe that PAM is indicative of our overall level of analytical activity, and we expect our period-to-period comparisons of our PAM to be indicative of underlying growth of our business, although changes in levels of analytical activity do not always directly translate to changes in financial performance of our business. Differences in fees charged for different analytical packages exist and differences in how analytics trigger the applicability of our data-driven intervention platforms may result in increases in analytical activity that do not result in proportional increases in revenue, or net income (and vice versa). Therefore, in situations in which a new engagement is initiated for analytical processes that have a higher than average fee rate, revenue could expand disproportionately faster than the increase in PAM. Likewise, if engagements for analytical processes that have a higher than average fee rate are concluded then such conclusions can negatively affect revenue disproportionately more than PAM.

Seasonality. The nature of our customers' end-market results in seasonality reflected in both revenue and cost of revenue differences during the year. Regulatory impact of data submission deadlines in, for example, March, June, September, and January drive predictable timing of analytics and data processing activity variances from quarter to quarter. Further, regulatory clinical encounter deadlines of June 30th and December 31st drive predictable intervention concentrations variances from quarter to quarter. The timing of these factors results in analytical and intervention activity mix variances which predictably impact financial performance from quarter to quarter. The trend of higher client focus on "watchful waiting" has increasingly shifted intervention platform usage to later in the year.

Macro-Economic and Macro-Industry Trends. Our clients are affected, sometimes directly, and sometimes counter-intuitively, by macro- economic trends such as economic growth (or economic recession), inflation, and unemployment. Further, industry trends in federal and state laws and regulations, as well as emerging trends in private sector payment models, affect our clients' businesses and their need for technologies and services to support these challenges. These factors have various effects on our business, and on occasion have resulted in the slowing or cessation of the decision-making process by clients adopting our technologies and services. On the other hand, changes in macro-economic trends and the industry landscape have accelerated the need for our technologies and services from time-to-time, particularly as regulators introduce complex requirements with which our clients must comply.

Shift to Fully Automated Data-Driven Intervention Platform Services. We view the decreased proportion of revenue derived from partially automated data-driven intervention platform services as a positive reflection of our cloud-based interconnectivity and automation capabilities. The proportion of our revenue derived from pure data analytics and fully automated data-driven intervention platform services revenue is expected to continue to expand over time as a percentage of total revenue as a result of our continued expansion of our cloud-based interconnectivity technologies and the continued expansion of interconnectivity within the healthcare landscape. In order to drive value for our clients and serve them irrespective of their level of connectivity, we continue to provide cloud-based partially automated data-driven intervention platform services, converting the performance of such services to cloud-based fully automated data-driven intervention platform services wherever possible. As the healthcare infrastructure becomes more interconnected and our integration and interconnectivity technologies continue to expand, we believe that we will be able to achieve more rapid implementation, and greater value impact, at more efficient costs.

Table of Contents

Critical Accounting Policies

Our discussion and analysis of our financial condition and results of operations are based on our condensed consolidated financial statements, which have been prepared in accordance with GAAP. In connection with the preparation of our condensed consolidated financial statements, we are required to make assumptions and estimates about future events, and apply judgments that affect the reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities as of the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. We base our assumptions, estimates, and judgments on historical experience, current trends, and other factors we believe to be relevant at the time we prepare our condensed consolidated financial statements. The accounting estimates used in the preparation of our condensed consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained, and as our operating environment changes. On a regular basis, we review the accounting policies, assumptions, and evaluate and update our assumptions, estimates, and judgments to ensure that our condensed consolidated financial statements are presented fairly and in accordance with GAAP. However, because future events and their effects cannot be determined with certainty, actual results could differ from our assumptions and estimates, and such differences could be material.

Critical accounting policies are those policies that affect our more significant judgments and estimates used in the preparation of our condensed consolidated financial statements. For a more detailed discussion of our critical accounting policies, please refer to our Annual Report on Form 10-K for the fiscal year ended December 31, 2015, filed with the SEC on February 26, 2016.

Components of Results of Operations

Revenue

We earn revenue primarily through the sale or subscription licensing of our cloud-based data analytics and data-driven intervention platform services.

Our cloud-based data analytics services are performed either at the beginning of a data-driven intervention process, which typically aligns with regulatory submission deadlines, or on a monthly basis, depending on the particular client's needs. Cloud-based data analytics revenue is driven primarily by the number of identified gaps in care, quality, data integrity, and financial performance identified in a client's dataset, the number of unique patients in a client's dataset, a minimum data analytics processing fee, and a contractually negotiated transactional price for each identified gap or unique patient. Subscription licensing revenue is driven primarily by the number of clients, the number of unique patients in a client's population dataset, the number of analytical services contracted for by a client, and the contractually negotiated price of such services.

Cloud-based data-driven intervention platform service revenue represents revenue that is generated from fully automated processes (i.e., those processes that require no material variable-based labor components) and partially automated processes (i.e., those processes that require a degree of variable-based labor components). The Company expects the expanding emphasis on data-driven analytics services, and therefore the increased share of Inovalon revenue from such services, to continue on a year-to-year basis. As many of our analytical capabilities are designed to identify gaps in care, quality, utilization, compliance, and/or other gaps that may impact our clients' achievement of greater healthcare quality and financial performance, our cloud-based data driven intervention platform services revenue is driven primarily by the results of our cloud-based data analytics processes and our clients' desire to utilize our cloud-based data-driven intervention platforms to resolve such identified gaps. Informed by our analytics, our cloud-based data-driven intervention platforms are designed to enable the resolution of specific gaps through the aggregation of specific data or achievement of specific impact. Revenue from our intervention platform utilization is generally driven by the quantity and type of completed interventions enabled by our platform, and a contractually negotiated transactional price for each such intervention.

Table of Contents

Cost of Revenue

Cost of revenue consists primarily of expenses for employees who provide direct contractual services to our clients, including salaries, benefits, discretionary incentive compensation, employment taxes, severance, and equity compensation costs. Cost of revenue also includes expenses associated with the integration, and verification of data and other service costs incurred to fulfill our revenue contracts. Cost of revenue does not include allocated amounts for occupancy expense and depreciation and amortization. Many of the elements of our cost of revenue are relatively variable and semi-variable, and can be reduced in the near-term to offset any decline in our revenue.

Our business and operational models are designed to be highly scalable and leverage variable costs to support revenue generating activities. While we expect to grow our headcount over time to capitalize on our market opportunities, we believe our increased investment in automation, electronic health record integration capabilities, and economies of scale in our operating model, will position us to grow our revenue at a greater rate than our cost of revenue, on an annual basis, excluding the impact of stock-based compensation expense.

Sales and Marketing

Sales and marketing expense consists primarily of employee-related expenses, including salaries, benefits, commissions, discretionary incentive compensation, employment taxes, severance, and equity compensation costs for our employees engaged in sales, sales support, business development, and marketing. Sales and marketing expense also includes operating expenses for marketing programs, research, trade shows and brand messages, and public relations costs. Our sales and marketing expense excludes any allocation of occupancy expense and depreciation and amortization.

We expect our sales and marketing expenses to increase as we strategically invest to expand our business. We expect to hire additional sales personnel and related support personnel to capture an increasing amount of our market opportunity. As we scale our sales and marketing activities in the short to medium term, we expect these expenses to increase in both absolute dollars and as a percentage of revenue.

Research and Development

Research and development expense (one component of our investment in innovation) consists primarily of employee-related expenses, including salaries, benefits, discretionary incentive compensation, employment taxes, severance, and equity compensation costs for our software developers, engineers, analysts, project managers, and other employees engaged in the development and enhancement of our service offerings. Research and development expense also includes certain third party consulting fees. Our research and development expense excludes any allocation of occupancy expense and depreciation and amortization.

We expect to continue our focus on developing new data analytics and data-driven intervention platforms and enhancing our existing data analytics and data-driven intervention platforms. As a result, we expect our research and development expense to increase in absolute dollars, although it may vary from period to period as a percentage of revenue.

General and Administrative

Our general and administrative expense consists primarily of employee-related expenses including salaries, benefits, discretionary incentive compensation, employment taxes, severance, and equity compensation costs, for employees who are responsible for management information systems, administration, human resources, finance, legal, and executive management. General and administrative expense also includes occupancy expenses (including rent, utilities, communications, and facilities

Table of Contents

maintenance), professional fees, consulting fees, insurance, travel, and other expenses. Our general and administrative expense excludes depreciation and amortization.

We expect our general and administrative expense to increase as we expand our business and incur the incremental costs associated with being a public company. However, excluding certain increases as a result of being a public company, and increases related to stock-based compensation and acquisition related costs, we expect our general and administrative expense to grow at a lower rate than revenue, on an annual basis.

Depreciation and Amortization Expense

Our depreciation and amortization expense consists primarily of depreciation of fixed assets, amortization of capitalized software development costs, and amortization of acquisition-related intangible assets.

Interest Income

Interest income represents interest earned from our short-term investments.

Interest Expense

Interest expense represents interest incurred on our Credit Facilities (as defined below).

Provision for Income Taxes

Provision for income taxes consists of federal and state income taxes in the United States and foreign income taxes from the territory of Puerto Rico, including deferred income taxes reflecting the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.

Table of Contents

RESULTS OF OPERATIONS

The following table set forth our consolidated statement of operations data for each of the periods presented (dollars in thousands):

	Three Months Ended March 31,						2015 to 2016 Change

	2016			2015			$			%
Revenue	$	102,657		$	93,633		$	9,024		10	%
Expenses:
Cost of revenue(1)	41,923			31,851			10,072			32	%
Sales and marketing(1)	6,559			1,850			4,709			255	%
Research and development(1)	5,932			5,411			521			10	%
General and administrative(1)	36,552			24,258			12,294			51	%
Depreciation and amortization	8,394			4,915			3,479			71	%

Total operating expenses	99,360			68,285			31,075			46	%

Income from operations	3,297			25,348			(22,051		)	(87	)%

Other income and (expenses):
Realized losses on short-term investments	(4		)	—			(4		)		*
Gain on disposal of equipment	534			—			534				*
Interest income	1,442			8			1,434				*
Interest expense	(1,259		)	(1,103		)	(156		)	14	%

Income before taxes	4,010			24,253			(20,243		)	(83	)%
Provision for income taxes	1,645			10,494			(8,849		)	(84	)%

Net income	$	2,365		$	13,759		$	(11,394	)	(83	)%

(1): Includes stock-based compensation expense as follows:


Cost of revenue	$	119	$	28	*	*
Sales and marketing	154		15		*	*
Research and development	242		362		*	*
General and administrative	1,577		1,367		*	*

Total stock-based compensation expense	$	2,092	$	1,772	*	*

*: Asterisk denotes not meaningful.

Table of Contents

The following table sets forth our consolidated statement of operations data for each of the periods presented as a percentage of revenue:

	Three Months Ended March 31,

	2016			2015
Revenue		100	%		100	%
Expenses:
Cost of revenue		41	%		34	%
Sales and marketing		6	%		2	%
Research and development		6	%		6	%
General and administrative		36	%		26	%
Depreciation and amortization		8	%		5	%

Total operating expenses		97	%		73	%

Income from operations		3	%		27	%

Other income and (expenses):
Realized losses on short-term investments		*	%		—	%
Gain on disposal of equipment		1	%		—	%
Interest income		1	%		—	%
Interest expense		(1	)%		(1	)%

Income before taxes		4	%		26	%
Provision for income taxes		2	%		11	%

Net income		2	%		15	%

*: Asterisk denotes not meaningful.

Comparison of the Three Months Ended March 31, 2016 and 2015

Revenue

Revenue during the three months ended March 31, 2016 increased by approximately $9.0 million, or 10%, compared with the three months ended March 31, 2015. The increase was primarily attributable to an increase in revenue from new clients of $13.8 million along with a net decrease of $4.8 million from existing clients.

Cost of Revenue

During the three months ended March 31, 2016, cost of revenue increased by approximately $10.1 million, or 32%, compared with the three months ended March 31, 2015. The $10.1 million increase in cost of revenue was primarily due to the corresponding increase in revenue of $9.0 million or 10%, that comprised a greater volume of data-driven intervention platform services as a percentage of revenue, and also resulted from a $3.5 million increase in employee-related expenses attributable to the September 2015 acquired data-driven advisory services service business. Cost of revenue as a percentage of revenue was 41% and 34% for the three months ended March 31, 2016 and 2015, respectively.

Sales and Marketing

During the three months ended March 31, 2016, sales and marketing expenses increased by approximately $4.7 million, compared with the three months ended March 31, 2015. The increase was

Table of Contents

primarily attributable to the growth of our sales and marketing team partially due to the acquisition of Avalere. The growth of our sales and marketing team was driven by our investment in additional sales personnel to focus on adding new clients and capturing an increased amount of our market opportunity.

Research and Development

During the three months ended March 31, 2016, research and development expense increased by approximately $0.5 million, or 10%, compared with the three months ended March 31, 2015. The increase was primarily attributable to growth in employee-related expenses necessary to support our on-going investment in innovation and platform development compared to the prior period.

General and Administrative

During the three months ended March 31, 2016, general and administrative expenses increased by approximately $12.3 million, or 51%, compared with the three months ended March 31, 2015. The increase in general and administrative expenses of $12.3 million includes incremental expenses that are not comparable to the prior year, comprised of $0.6 million for integration related severance costs, $3.2 million of post-acquisition contingent consideration expense related to the acquisition of Avalere, $0.2 million of incremental stock-based compensation expense, $0.1 million for employer taxes related to stock option awards exercised by employees, and $0.8 million of employee severance expenses. In addition, compared to the three months ended March 31, 2015, we increased our investment in incremental personnel to support our growth, including the acquisition of Avalere, resulting in an overall increase for employee-related expenses of $7.4 million.

Depreciation and Amortization

During the three months ended March 31, 2016, depreciation and amortization expense increased by approximately $3.5 million, or 71%, compared with the three months ended March 31, 2015. The increase is attributable to $1.9 million amortization of intangible assets related to the acquisition of Avalere, and increased amortization of capitalized software of $1.6 million, as compared with the three months ended March 31, 2015.

Gain on Disposal of Equipment

During the three months ended March 31, 2016, we replaced certain data-center equipment. The replacement of the equipment was covered under our insurance and the cost of our replacement equipment has since been reimbursed by our insurance carrier. As a result, the disposal of the equipment resulted in a gain of $0.5 million.

Interest Income

During the three months ended March 31, 2016, interest income increased by approximately $1.4 million, compared with the three months ended March 31, 2015. Interest income for the three months ended March 31, 2016 is attributable to earnings derived from the Company's available-for-sale short-term investments.

Interest Expense

During the three months ended March 31, 2016, interest expense increased by approximately $0.2 million, compared with the three months ended March 31, 2015. The increase was attributable to interest expense on our Term Loan Facility (as defined below).

Table of Contents

Provision for Income Taxes

During the three months ended March 31, 2016, provision for income taxes decreased by approximately $8.8 million, or 84%, compared to the three months ended March 31, 2015. The decrease was primarily driven by the decrease in income before taxes and to a lesser extent the effective tax rate of 41% for the three months ended March 31, 2016 compared to 43% in the same period of the prior year.

Liquidity and Capital Resources

Sources of Liquidity

Our principal sources of liquidity have been cash generated by operating activities, proceeds from our initial public offering and Credit Facilities. Our cash generated from such means has been sufficient to fund our growth, including our capital expenditures. As of March 31, 2016, our cash, cash equivalents and short-term investments totaled $738.5 million, of which $611.6 million represented short-term, available-for-sale, investment grade, domestic debt-securities, compared to $793.1 million of cash and cash equivalents as of March 31, 2015.

We believe our current cash, cash equivalents, and short-term investments balance, expected cash generated by operating activities and availability of cash under our Credit Facilities is sufficient to fund our operations, finance our strategic initiatives, fund our investment in innovation and new service offerings, and fund our share repurchase program, for the foreseeable future. There can be no assurance that we will continue to generate cash flows at or above current levels or that we will be able to maintain our ability to borrow under our Credit Facilities.

Debt

On September 19, 2014, we entered into a Credit and Guaranty Agreement with a group of lenders including Goldman Sachs Bank USA, as administrative agent (the "Credit Agreement"). The terms of the Credit Agreement provide for credit facilities in the aggregate maximum principal amount of $400.0 million, consisting of a senior unsecured term loan facility in the original principal amount of $300.0 million (the "Term Loan Facility") and a senior unsecured revolving credit facility in the maximum principal amount of $100.0 million (the "Revolving Credit Facility" and, together with the Term Loan Facility, the "Credit Facilities"). As of March 31, 2016, we had outstanding indebtedness under the Term Loan Facility and capital lease obligations of $277.5 million and $0.4 million, respectively, and had outstanding indebtedness under our Term Loan Facility and capital lease obligations of $295.0 million and $0.1 million, respectively as of March 31, 2015. The Term Loan Facility has a five-year term. The Term Loan Facility is an amortizing facility with principal payments quarterly and interest payments monthly. A scheduled principal payment of $3.8 million and interest payments totaling $1.2 million were paid during the three months ended March 31, 2016. As of March 31, 2016, we were in compliance with the covenants under the Credit Agreement.

Cash Flows

Operating Cash Flow Activities

Cash provided by operating activities during the three months ended March 31, 2016 was approximately $14.3 million, an increase in cash inflow of approximately $13.5 million compared with the three months ended March 31, 2015. Cash provided by operating activities was driven by net income of approximately $2.4 million, as adjusted for the exclusion of non-cash expenses totaling approximately $8.8 million, which was augmented by approximately $3.1 million related to the effect of changes in working capital and other balance sheet accounts.

Table of Contents

Investing Cash Flow Activities

Cash used in investing activities in the three months ended March 31, 2016 was approximately $2.2 million, a decrease in cash outflow of approximately $4.3 million compared with the three months ended March 31, 2015. The cash used for investing purposes was primarily due to purchases of property and equipment of $4.1 million, investments in capitalized software of approximately $2.8 million, and was offset by proceeds generated from sales and maturities of available-for-sale securities, net of purchases, of approximately $4.6 million.

We make investments in innovation, including research and development expense, capital software development costs, and research and development infrastructure investments, on a recurring basis. We expect our investment in innovation to increase in the foreseeable future to support our continued growth and new service offerings.

Financing Cash Flow Activities

Cash provided by financing activities during the three months ended March 31, 2016 was approximately $0.8 million, a decrease of approximately $635.4 million in cash inflow compared with the three months ended March 31, 2015. The cash provided by financing activities during the three months ended March 31, 2016 is primarily comprised of approximately $3.8 million of proceeds received from the exercise of stock options and $0.9 million of excess tax benefits from stock-based compensation, partially offset by $3.8 million for the repayment of credit facility borrowings and $0.2 million of employer tax payments related to the issuance of vested equity awards.

Contractual Obligations

During the three months ended March 31, 2016, there have been no material changes, outside of the ordinary course of business, in our contractual obligations previously disclosed under the caption "Contractual Obligations" in our Annual Report on Form 10-K for the year ended December 31, 2015 filed with the SEC on February 26, 2016.

Off-Balance Sheet Arrangements

As of March 31, 2016, we did not have any off-balance sheet arrangements.

Recently Issued Accounting Standards

Recently issued accounting standards and their expected impact, if any, are discussed in Note 1, "Basis of Presentation", of the notes to our condensed consolidated financial statements, included under Item 1 within this Quarterly Report on Form 10-Q and in Note 2 "Summary of Significant Accounting Policies," in the notes to our consolidated financial statements, included under Item 15 within our Annual Report on Form 10-K for the year ended December 31, 2015, filed with the SEC on February 26, 2016.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Variable Rate Debt Risk. Our variable rate debt includes our Term Loan Facility and our Revolving Credit Facility. As of March 31, 2016, we had $277.5 million outstanding under our Term Loan Facility at an effective interest rate of 1.7%. As a result, if market interest rates were to increase by 1.0%, or 100 basis points, interest expense would decrease future earnings and cash flows, net of estimated tax benefits, by approximately $1.6 million annually, assuming that we do not enter into contractual hedging arrangements. As of March 31, 2016, there was no balance outstanding on the Revolving Credit Facility.

Table of Contents

Marketable Securities Risk. We had short-term investments totaling approximately $611.6 million as of March 31, 2016. This amount was invested primarily in marketable securities including corporate notes and bonds, U.S. agency obligations, commercial paper, U.S. treasury securities, certificates of deposit and money market funds. Our investments are made for capital preservation purposes. We do not enter into investments for trading or speculative purposes.

Our short-term investments are subject to market risk due to changes in interest rates, which could affect our results of operations. Fixed rate securities may have their market value adversely affected due to a rise in interest rates, while floating rate securities may produce less income than expected if interest rates fall. Due in part to these factors, our future investment income may fluctuate due to changes in interest rates or we may suffer losses in principal if we are forced to sell securities that decline in market value due to changes in interest rates. However because we classify our marketable securities as "available for sale," no gains or losses are recognized due to changes in interest rates unless such securities are sold prior to maturity or declines in fair value are determined to be other-than-temporary.

An immediate increase of 100-basis points in interest rates would have resulted in an approximate $4.9 million market value reduction in our investment portfolio as of March 31, 2016. An immediate decrease of 100-basis points in interest rates would have increased the market value by approximately $10.3 million as of March 31, 2016. This estimate is based on a sensitivity model that measures market value changes when changes in interest rates occur. Fluctuations in the value of our investment securities caused by a change in interest rates (gains or losses on the carrying value) are recorded in accumulated other comprehensive income (loss), and are realized only if we sell the underlying securities prior to their maturity.

Item 4. Controls and Procedures

Disclosure Controls and Procedures

Our management, with the participation of our chief executive officer ("CEO") and chief financial officer ("CFO"), has evaluated the effectiveness of our disclosure controls and procedures, (as defined in Rules 13a- 15(e) and 15d- 15(e) under the Exchange Act), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on such evaluation, our CEO and CFO have concluded that, as of March 31, 2016, our disclosure controls and procedures are designed at a reasonable assurance level and are effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control

There have been no changes in the our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the three months ended March 31, 2016 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II—OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, we may be involved in various legal proceedings and subject to claims that arise in the ordinary course of business. Although the results of litigation and claims are inherently unpredictable and uncertain, we are not currently a party to any legal proceedings the outcome of which, if determined adversely to us, are believed to, either individually or taken together, have a material adverse effect on our business, operating results, cash flows or financial condition. Regardless of the outcome, litigation has the potential to have an adverse impact on us because of defense and settlement costs, diversion of management resources, and other factors.

Item 1A. Risk Factors

For a discussion of potential risks and uncertainties related to our Company see the information in Part I, Item 1A ("Risk Factors") of our Annual Report on Form 10-K for the year ended December 31, 2015. There have been no material changes to the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2015.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Unregistered Sales of Equity Securities

None.

Use of Proceeds from Registered Securities

On February 18, 2015, we completed our initial public offering ("IPO") of 22,222,222 shares of Class A common stock and, upon the underwriters' exercise of their option to purchase additional shares, issued an additional 3,142,581 shares of Class A common stock for a total of 25,364,803 shares issued. All of the shares issued in the IPO were primary shares offered by us as none of our stockholders sold any shares in the IPO. The offering price of the shares sold in the IPO was $27.00 per share, resulting in net proceeds to us, after underwriters' discounts and commissions and other expenses payable by us, of $639.1 million. All of the shares were sold pursuant to our registration statement on Form S-1, as amended (File No. 333-201321), that was declared effective by the SEC on February 11, 2015. Goldman, Sachs & Co., Morgan Stanley & Co. LLC, and Citigroup Global Markets Inc. acted as joint book-running managers for the IPO and as representatives of the underwriters. The principal purposes of our IPO were to create a public market for our Class A common stock and thereby enable future access to the public equity markets by us and our stockholders, and obtain additional capital. On September 1, 2015, we used approximately $126.2 million of the net proceeds from the IPO to complete the acquisition of Avalere. We intend to use the remaining net proceeds to us from our IPO for working capital and other general corporate purposes; other than funding the share repurchase program, we do not currently have any specific uses of the remaining net proceeds. Additionally, we may use a portion of the remaining net proceeds for additional acquisitions of complementary businesses, technologies, or other assets, or to repay outstanding indebtedness.

Table of Contents

Purchases of Equity Securities by the Issuer or Affiliated Purchasers

The following table sets forth certain information with respect to common stock purchased by the Company for the three-month period ended March 31, 2016.

Period			Average Price Paid per Share

January	—			—	—	—
February	33,148	(1)	$	17.96	—	—
March	—			—	—	—

Total	33,148	(1)	$	17.96	—	—

(1): On February 29, 2016, we directed the administrator of the Company's Employee Stock Purchase Plan ("ESPP") to purchase 33,148 shares of Class A common stock in the open market for a total of approximately $0.6 million, for issuance to the ESPP participants at a discounted price of $14.61 per share. The Company may, in its discretion, based on market conditions, relative transaction costs and the Company's need for additional capital, continue to instruct the plan administrator to make semi-annual open market purchases of Class A common stock for ESPP participants to coincide with the ESPP's designated semi-annual purchase dates.

Item 3. Defaults Upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

Item 6. Exhibits

Table of Contents

EXHIBIT INDEX

		Description of Document

31.1	*	Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2	*	Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1	**	Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2	**	Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS	*	XBRL Instance Document

101.SCH	*	XBRL Taxonomy Extension Schema

101.CAL	*	XBRL Taxonomy Extension Calculation Linkbase

101.DEF	*	XBRL Taxonomy Extension Definition Linkbase

101.LAB	*	XBRL Taxonomy Extension Label Linkbase

101.PRE	*	XBRL Taxonomy Extension Presentation Linkbase

*: Filed herewith.
**: This certification is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (Exchange Act), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended (Securities Act), or the Exchange Act.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


Date: May 5, 2016	INOVALON HOLDINGS, INC.
	By:	/s/ KEITH R. DUNLEAVY, M.D. Keith R. Dunleavy, M.D. Chief Executive Officer and Chairman (Principal Executive Officer)
	By:	/s/ THOMAS R. KLOSTER Thomas R. Kloster Chief Financial Officer (Principal Financial Officer & Principal Accounting Officer)

EX-31.1 2 a2228514zex-31_1.htm EX-31.1
QuickLinks -- Click here to rapidly navigate through this document

EXHIBIT 31.1

CERTIFICATION

I, Keith R. Dunleavy, M.D., certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Inovalon Holdings, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's Board of Directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


		/s/ KEITH R. DUNLEAVY, M.D. Keith R. Dunleavy, M.D. Chief Executive Officer and Chairman (Principal Executive Officer)

Date: May 5, 2016

QuickLinks

EXHIBIT 31.1

CERTIFICATION
EX-31.2 3 a2228514zex-31_2.htm EX-31.2
QuickLinks -- Click here to rapidly navigate through this document

EXHIBIT 31.2

CERTIFICATION

I, Thomas R. Kloster, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Inovalon Holdings, Inc.;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


		/s/ THOMAS R. KLOSTER Thomas R. Kloster Chief Financial Officer (Principal Financial & Principal Accounting Officer)

Date: May 5, 2016

QuickLinks

EXHIBIT 31.2

CERTIFICATION
EX-32.1 4 a2228514zex-32_1.htm EX-32.1
QuickLinks -- Click here to rapidly navigate through this document

EXHIBIT 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Inovalon Holdings, Inc. (the "Company") on Form 10-Q for the period ended March 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Keith R. Dunleavy, M.D., the Chief Executive Officer and Chairman of the Company, certify, to my knowledge, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.: the Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and
2.: the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


		/s/ KEITH R. DUNLEAVY, M.D. Keith R. Dunleavy, M.D. Chief Executive Officer and Chairman (Principal Executive Officer)

Date: May 5, 2016

QuickLinks

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
EX-32.2 5 a2228514zex-32_2.htm EX-32.2
QuickLinks -- Click here to rapidly navigate through this document

Exhibit 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Inovalon Holdings, Inc. (the "Company") on Form 10-Q for the period ended March 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Thomas R. Kloster, Chief Financial Officer of the Company, certify, to my knowledge, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.: the Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and
2.: the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


		/s/ THOMAS R. KLOSTER Thomas R. Kloster Chief Financial Officer (Principal Financial & Principal Accounting Officer)

Date: May 5, 2016

QuickLinks

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
EX-101.INS 6 inov-20160331.xml EX-101.INS 0001619954 us-gaap:FairValueInputsLevel3Member inov:BusinessCombinationContingentConsiderationLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2016-03-31 0001619954 inov:BusinessCombinationContingentConsiderationLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2016-03-31 0001619954 us-gaap:FairValueInputsLevel3Member inov:BusinessCombinationContingentConsiderationLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001619954 inov:BusinessCombinationContingentConsiderationLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001619954 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2016-03-31 0001619954 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2016-03-31 0001619954 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2016-03-31 0001619954 us-gaap:FairValueMeasurementsRecurringMember 2016-03-31 0001619954 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001619954 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001619954 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001619954 us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001619954 inov:BusinessCombinationContingentConsiderationLiabilityMember us-gaap:GeneralAndAdministrativeExpenseMember 2016-01-01 2016-03-31 0001619954 us-gaap:CommonClassBMember 2016-03-31 0001619954 us-gaap:CommonClassAMember 2016-03-31 0001619954 us-gaap:CommonClassBMember 2015-12-31 0001619954 us-gaap:CommonClassAMember 2015-12-31 0001619954 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2016-03-31 0001619954 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2016-03-31 0001619954 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001619954 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001619954 2015-03-31 0001619954 2014-12-31 0001619954 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2016-03-31 0001619954 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2016-03-31 0001619954 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2016-03-31 0001619954 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2016-03-31 0001619954 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2016-03-31 0001619954 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2016-03-31 0001619954 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2016-03-31 0001619954 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2016-03-31 0001619954 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2016-03-31 0001619954 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2016-03-31 0001619954 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2015-12-31 0001619954 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2015-12-31 0001619954 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2015-12-31 0001619954 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2015-12-31 0001619954 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2015-12-31 0001619954 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2015-12-31 0001619954 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2015-12-31 0001619954 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2015-12-31 0001619954 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2015-12-31 0001619954 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2015-12-31 0001619954 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2016-01-01 2016-03-31 0001619954 us-gaap:CorporateDebtSecuritiesMember 2016-01-01 2016-03-31 0001619954 us-gaap:CommercialPaperMember 2016-01-01 2016-03-31 0001619954 us-gaap:CommercialPaperMember 2015-12-31 0001619954 us-gaap:CertificatesOfDepositMember 2015-12-31 0001619954 us-gaap:USTreasurySecuritiesMember 2016-03-31 0001619954 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2016-03-31 0001619954 us-gaap:CorporateDebtSecuritiesMember 2016-03-31 0001619954 us-gaap:CommercialPaperMember 2016-03-31 0001619954 us-gaap:CertificatesOfDepositMember 2016-03-31 0001619954 us-gaap:USTreasurySecuritiesMember 2015-12-31 0001619954 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2015-12-31 0001619954 us-gaap:CorporateDebtSecuritiesMember 2015-12-31 0001619954 us-gaap:StockCompensationPlanMember 2016-01-01 2016-03-31 0001619954 us-gaap:StockCompensationPlanMember 2015-01-01 2015-03-31 0001619954 us-gaap:SellingAndMarketingExpenseMember 2016-01-01 2016-03-31 0001619954 us-gaap:ResearchAndDevelopmentExpenseMember 2016-01-01 2016-03-31 0001619954 us-gaap:GeneralAndAdministrativeExpenseMember 2016-01-01 2016-03-31 0001619954 us-gaap:CostOfSalesMember 2016-01-01 2016-03-31 0001619954 us-gaap:SellingAndMarketingExpenseMember 2015-01-01 2015-03-31 0001619954 us-gaap:ResearchAndDevelopmentExpenseMember 2015-01-01 2015-03-31 0001619954 us-gaap:GeneralAndAdministrativeExpenseMember 2015-01-01 2015-03-31 0001619954 us-gaap:CostOfSalesMember 2015-01-01 2015-03-31 0001619954 2015-01-01 2015-03-31 0001619954 2016-03-31 0001619954 2015-12-31 0001619954 us-gaap:CommonClassBMember 2016-04-30 0001619954 us-gaap:CommonClassAMember 2016-04-30 0001619954 2016-01-01 2016-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares false --12-31 Q1 2016 2016-03-31 10-Q 0001619954 66905308 85437106 Yes Non-accelerated Filer Inovalon Holdings, Inc. 206679000 217876000 407451000 393722000 464000 53000 797000 843000 2446000 2251000 -109000 -149000 2180000 5158000 2790000 88000 182000

21136000

17716000

81305000

73177000

-871000

-1582000

806000

493197000

499899000

1772000

28000

1367000

362000

15000

2092000

119000

1577000

242000

154000

1022000

1320000

542000

1827000

23000

110000

1112877000

1117107000

844008000

850128000

25000

12000

11000

2000

809000

4000

66000

620000

43000

76000

2740000

9000

28000

2321000

203000

179000

574000

6000

528000

13000

27000

616845000

7928000

36849000

390185000

121521000

60362000

611363000

6251000

29798000

407461000

97562000

70291000

574000

6000

528000

13000

352123000

961000

12475000

257125000

30585000

614130000

7919000

36821000

387876000

121329000

60185000

7919000

36821000

387876000

121329000

60185000

7919000

36821000

387876000

121329000

60185000

611598000

6255000

29858000

407553000

97592000

70340000

6255000

29858000

407553000

97592000

70340000

6255000

29858000

407553000

97592000

70340000

-4000

1557000

933000

109000

296000

309000

162567000

793114000

114034000

126885000

2521000

19298000

630547000

12851000

0.000005

900000000

750000000

150000000

900000000

750000000

150000000

53482669

98230363

66129038

86235350

53482669

98230363

66129038

86235350

1000

13759000

4753000

31851000

41923000

68285000

99360000

-493000

-1252000

5507000

7044000

37198000

36275000

4373000

6567000

4915000

8394000

0.10

0.02

0.10

0.02

13538000

10281000

911000

<div> <div style="margin-left:0%;margin-right:0%;"></div><div style="margin-left:0%;margin-right:0%;">   4. FAIR VALUE MEASUREMENTS (in thousands)         The following table presents the fair value hierarchy for financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2016:                                                                                                                                                                                      <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;CellSpacing:0;margin-left:0pt;"> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Level 1 </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Level 2 </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Level 3 </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Cash Equivalents: </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> Money market funds </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>19,298 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>19,298 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Short-term investments: </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> Corporate notes and bonds </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>407,553 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>407,553 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> U.S. agency obligations </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>97,592 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>97,592 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> U.S. treasury securities </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>70,340 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>70,340 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Commercial paper </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>29,858 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>29,858 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> Certificates of deposit </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,255 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,255 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Other Current Liabilities: </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> Contingent consideration </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(2,300 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(2,300 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;"> ) </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Total </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>19,298 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>611,598 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(2,300 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>628,596 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> </table></div>         The following table presents the fair value hierarchy for financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2015:                                                                                                                                                                                      <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;CellSpacing:0;margin-left:0pt;"> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Level 1 </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Level 2 </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Level 3 </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Cash Equivalents: </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> Money market funds </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,521 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,521 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Short-term investments: </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> Corporate notes and bonds </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>387,876 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>387,876 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> U.S. agency obligations </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>121,329 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>121,329 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> U.S. treasury securities </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>60,185 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>60,185 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Commercial paper </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>36,821 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>36,821 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> Certificates of deposit </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,919 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,919 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Other Current Liabilities: </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> Contingent consideration </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(2,300 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(2,300 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;"> ) </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Total </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,521 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>614,130 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(2,300 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>614,351 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> </table></div>         The Company determines the fair value of its security holdings based on pricing from its pricing vendors. The valuation techniques used to measure the fair value of financial instruments having Level 2 inputs were derived from non-binding consensus prices that are corroborated by observable market data or quoted market prices for similar instruments. Such market prices may be quoted prices in active markets for identical assets (Level 1 inputs) or pricing determined using inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs). The Company performs procedures to ensure that appropriate fair values are recorded such as comparing prices obtained from other sources.         On September 1, 2015, the Company recorded contingent consideration at its fair value in conjunction with the acquisition of Avalere Health, Inc. The Company determines fair value of its contingent consideration, using Level 3 inputs under the fair value hierarchy, consisting of information provided by observing certain operating metrics along with management's own assumptions. The Company adjusts the estimated fair value of its contingent consideration quarterly, if there is a change in the aforementioned factors considered in determining the fair value of the contingent consideration. The change in value, if any, is reflected in the Company's statements of operations as gain (loss) from contingent consideration valuation as a component of general and administrative expenses. For the three months ended March 31, 2016 there was no change in the fair value of the contingent consideration. </div><div style="margin-left:0%;margin-right:0%;"> </div><div style="margin-left:0%;margin-right:0%;"></div> </div>

614351000

2521000

614130000

-2300000

628596000

19298000

611598000

-2300000

2300000

61855000

60028000

534000

-4000

24258000

36552000

137733000

24253000

4010000

1583000

861000

18377000

17251000

10494000

1645000

-1685000

-2194000

21703000

-8128000

2554000

613000

1537000

-6368000

-3877000

-6797000

-2037000

655000

2676000

171000

-78000

-277000

5054000

1103000

1259000

8000

1442000

1076000

1195000

<div> <div style="margin-left:0%;margin-right:0%;"></div><div style="margin-left:0%;margin-right:0%;">   3. SHORT-TERM INVESTMENTS(in thousands)         As of March 31, 2016, short-term investments consisted of the following:                                                                                                                                                                                      <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;CellSpacing:0;margin-left:0pt;"> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Amortized Cost </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Gross Unrealized Gains </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Gross Unrealized Losses </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Estimated Fair Value </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Available-for-sale securities: </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> Corporate notes and bonds </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>407,461 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>620 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(528 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>407,553 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> U.S. agency obligations </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>97,562 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>43 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(13 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>97,592 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> U.S. treasury securities </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>70,291 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>76 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(27 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>70,340 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Commercial paper </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>29,798 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>66 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(6 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>29,858 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> Certificates of deposit </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,251 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,255 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Total available-for-sale securities </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>611,363 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>809 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(574 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>611,598 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> </table></div>         As of December 31, 2015, short-term investments consisted of the following:                                                                                                                                                                                      <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;CellSpacing:0;margin-left:0pt;"> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Amortized Cost </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Gross Unrealized Gains </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Gross Unrealized Losses </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Estimated Fair Value </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Available-for-sale securities: </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> Corporate notes and bonds </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>390,185 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>12 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(2,321 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>387,876 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> U.S. agency obligations </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>121,521 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(203 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>121,329 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> U.S. treasury securities </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>60,362 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(179 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>60,185 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Commercial paper </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>36,849 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(28 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>36,821 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> Certificates of deposit </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,928 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(9 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,919 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Total available-for-sale securities </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>616,845 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>25 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(2,740 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>614,130 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> </table></div>         The following table summarizes the estimated fair value of our short-term investments, designated as available-for-sale and classified by the contractual maturity date of the securities as of the dates shown:                                                                                                                                                                                      <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;CellSpacing:0;margin-left:0pt;"> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> March 31, 2016 </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> December 31, 2015 </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Due in one year or less </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>217,876  </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>206,679  </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> Due after one year through three years </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>393,722  </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>407,451  </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Total </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>611,598  </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>614,130  </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> </table></div>         The Company has certain available-for-sale securities in a gross unrealized loss position, all of which have been in such position for less than 12 months. The Company reviews its debt securities classified as short-term investments on a regular basis to evaluate whether or not any security has experienced an other-than-temporary decline in fair value. The Company considers factors such as the length of time and extent to which the market value has been less than the cost, the financial position and near-term prospects of the issuer and the Company's intent to sell, or whether it is more likely than not the Company will be required to sell the investment before recovery of the investment's amortized-cost basis. If the Company determines that an other-than-temporary decline exists, or if write downs related to credit losses are necessary, in one of these securities, the unrealized losses attributable to the respective investment would be reclassified to realized losses on short-term investments within the statement of operations. There were no impairments considered other-than-temporary as of March 31, 2016.         The following table shows the fair values and the gross unrealized losses of available-for-sale securities that have been in a gross unrealized loss position for less than 12 months, aggregated by investment category as of March 31, 2016:                                                                                                                                                                                      <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;CellSpacing:0;margin-left:0pt;"> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Estimated Fair Value </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Gross Unrealized Losses </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Corporate notes and bonds </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>257,125 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(528 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;"> ) </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> U.S. agency obligations </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>30,585 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(13 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;"> ) </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> U.S. treasury securities </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>50,977 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(27 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;"> ) </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> Commercial paper </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>12,475 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(6 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;"> ) </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Certificates of deposit </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>961 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>352,123 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(574 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;"> ) </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> </table></div>   </div><div style="margin-left:0%;margin-right:0%;"> </div><div style="margin-left:0%;margin-right:0%;"></div> </div>

373721000

366496000

1112877000

1117107000

67531000

68911000

15000000

18750000

266250000

258750000

636226000

789000

-6496000

-2237000

817000

14299000

13759000

2365000

13759000

2356000

13759000

2356000

25348000

3297000

4250000

3940000

-3000

1000

2385000

-560000

11444000

14168000

3002000

1338000

4053000

80065000

0.0001

100000000

16162000

21217000

362082000

84671000

282172000

3841000

65031000

65278000

26000

31000

5000000

3750000

5411000

5932000

247540000

249905000

93633000

102657000

<div> <div style="margin-left:0%;margin-right:0%;"></div><div style="margin-left:0%;margin-right:0%;">           The following table presents the fair value hierarchy for financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2016:                                                                                                                                                                                      <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;CellSpacing:0;margin-left:0pt;"> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Level 1 </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Level 2 </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Level 3 </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Cash Equivalents: </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> Money market funds </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>19,298 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>19,298 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Short-term investments: </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> Corporate notes and bonds </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>407,553 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>407,553 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> U.S. agency obligations </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>97,592 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>97,592 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> U.S. treasury securities </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>70,340 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>70,340 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Commercial paper </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>29,858 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>29,858 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> Certificates of deposit </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,255 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,255 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Other Current Liabilities: </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> Contingent consideration </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(2,300 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(2,300 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;"> ) </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Total </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>19,298 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>611,598 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(2,300 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>628,596 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> </table></div>         The following table presents the fair value hierarchy for financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2015:                                                                                                                                                                                      <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;CellSpacing:0;margin-left:0pt;"> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Level 1 </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Level 2 </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Level 3 </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Cash Equivalents: </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> Money market funds </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,521 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,521 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Short-term investments: </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> Corporate notes and bonds </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>387,876 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>387,876 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> U.S. agency obligations </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>121,329 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>121,329 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> U.S. treasury securities </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>60,185 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>60,185 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Commercial paper </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>36,821 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>36,821 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> Certificates of deposit </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,919 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,919 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Other Current Liabilities: </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> Contingent consideration </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(2,300 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(2,300 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;"> ) </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Total </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,521 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>614,130 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(2,300 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>614,351 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> </table></div>   </div><div style="margin-left:0%;margin-right:0%;"> </div><div style="margin-left:0%;margin-right:0%;"></div> </div>

1850000

6559000

1772000

2092000

739156000

750611000

-9000

3571000

1073000

138902000

152355000

135331000

151282000

Includes stock-based compensation expense as follows: Three months ended March 31, 2016: Cost of revenue 119; Sales and marketing 154; Research and development 242; General and administrative 1,577; Total stock-based compensation expense 2,092. Three months ended March 31, 2015: Cost of revenue 28; Sales and marketing 15; Research and development 362; General and administrative 1,367; Total stock-based compensation expense 1,772.

EX-101.SCH 7 inov-20160331.xsd EX-101.SCH 00100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - NET INCOME PER SHARE - Tabular Disclosure (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - SHORT-TERM INVESTMENTS - Available-for-sale Securities (Details) link:presentationLink link:calculationLink link:definitionLink 40302 - Disclosure - SHORT-TERM INVESTMENTS - Estimated Fair Value by Contractual Maturity Date (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - FAIR VALUE MEASUREMENTS - Fair Value Hierarchy Table (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00205 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00305 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - NET INCOME PER SHARE link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - SHORT-TERM INVESTMENTS link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 20102 - Disclosure - BASIS OF PRESENTATION (Policies) link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - NET INCOME PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 30303 - Disclosure - SHORT-TERM INVESTMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 30403 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - NET INCOME PER SHARE - Anti-dilutive Securities (Details) link:presentationLink link:calculationLink link:definitionLink 40303 - Disclosure - SHORT-TERM INVESTMENTS - Other-than-temporary Impairments (Details) link:presentationLink link:calculationLink link:definitionLink 40304 - Disclosure - SHORT-TERM INVESTMENTS - Fair Values and Gross Unrealized Losses of Available-for-sale Securities in a Gross Loss Position for Less than Twelve Months (Details) link:presentationLink link:calculationLink link:definitionLink 40402 - Disclosure - FAIR VALUE MEASUREMENTS - Contingent Consideration (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 inov-20160331_cal.xml EX-101.CAL EX-101.LAB 9 inov-20160331_lab.xml EX-101.LAB Document and Entity Information [Abstract] Statement [Table] Statement [Line Items] Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Current Reporting Status Entity Filer Category Entity Common Stock, Shares Outstanding Document Fiscal Year Focus Document Fiscal Period Focus CONDENSED CONSOLIDATED BALANCE SHEETS Assets [Abstract] ASSETS Assets, Current [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents, end of period Cash and cash equivalents, beginning of period Cash and cash equivalents Available-for-sale Securities, Current Estimated Fair Value Total Short-term investments Accounts Receivable, Net, Current Accounts receivable (net of allowances of $1,320 and $1,022 at March 31, 2016 and December 31, 2015, respectively) Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Income Taxes Receivable, Current Income tax receivable Assets, Current Total current assets Assets, Noncurrent [Abstract] Noncurrent assets: Property, Plant and Equipment, Net Property, equipment and capitalized software, net Goodwill Goodwill Finite-Lived Intangible Assets, Net Intangible assets, net Other Assets, Noncurrent Other assets Assets Total assets Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) Liabilities [Abstract] LIABILITIES Liabilities, Current [Abstract] Current liabilities: Accounts Payable, Current Accounts payable Employee-related Liabilities, Current Accrued compensation Other Liabilities, Current Other current liabilities Deferred Revenue, Current Deferred revenue For a classified balance sheet, the cumulative difference between the rental payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense over the term of the leased property by the lessor or lessee, respectively, within one year of the balance sheet date, and the deferred credit for an incentive or inducement received by a lessee from a lessor, in order to motivate the lessee to enter the lease agreement, which incentive or inducement is to be recognized as a reduction of rental expense over the lease term within one year of the balance sheet date. Deferred Rent Credit and Incentive from Lessor, Current Deferred rent Line of Credit, Current Credit facilities Capital Lease Obligations, Current Capital lease obligation Liabilities, Current Total current liabilities Liabilities, Noncurrent [Abstract] Noncurrent liabilities: Long-term Line of Credit, Noncurrent Credit facilities, less current portion Capital Lease Obligations, Noncurrent Capital lease obligation, less current portion For a classified balance sheet, the cumulative difference between the rental payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense over the term of the leased property by the lessor or lessee, respectively, more than one year after the balance sheet date, and the deferred credit for an incentive or inducement received by a lessee from a lessor, in order to motivate the lessee to enter the lease agreement, which incentive or inducement is to be recognized as a reduction of rental expense over the lease term more than one year after the balance sheet date. Deferred Rent Credit and Incentive from Lessor, Noncurrent Deferred rent Deferred Tax Liabilities, Net, Noncurrent Deferred income taxes Liabilities Total liabilities Commitments and Contingencies. Commitments and contingencies (Note 5) Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] STOCKHOLDERS' EQUITY Stockholders' Equity Attributable to Parent [Abstract] Stockholders' equity: Common Stock, Value, Issued Common stock Preferred Stock, Value, Issued Preferred stock, $0.0001 par value, 100,000,000 shares authorized, zero shares issued and outstanding at March 31, 2016 and December 31, 2015, respectively Additional Paid in Capital Additional paid-in-capital Retained Earnings (Accumulated Deficit) Retained earnings Accumulated Other Comprehensive Income (Loss), Net of Tax Other comprehensive loss (loss) Stockholders' Equity Attributable to Parent Total stockholders' equity Liabilities and Equity Total liabilities and stockholders' equity Accounts Receivable, Net, Current [Abstract] Accounts receivable, allowances Allowance for Doubtful Accounts Receivable, Current Accounts receivable, allowances (in dollars) Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract] Common stock Common Stock, Par or Stated Value Per Share Common stock, par value (in dollars per share) Common Stock, Shares Authorized Common stock, authorized shares Common Stock, Shares, Issued Common stock, issued shares Common Stock, Shares, Outstanding Common stock, outstanding shares Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract] Preferred stock Preferred Stock, Par or Stated Value Per Share Preferred stock, par value (in dollars per share) Preferred Stock, Shares Authorized Preferred stock, Authorized shares Preferred Stock, Shares Issued Preferred stock, issued shares Preferred Stock, Shares Outstanding Preferred stock, outstanding shares CONDENSED CONSOLIDATED STATEMENTS OF INCOME Revenue, Net [Abstract] CONDENSED CONSOLIDATED STATEMENTS OF INCOME Revenue, Net Revenue Costs and Expenses [Abstract] Expenses: Cost of Revenue. Cost of revenue Selling and Marketing Expense Sales and marketing Research and Development Expense Research and development General and Administrative Expense. General and administrative Depreciation, Depletion and Amortization Depreciation and amortization Costs and Expenses Total operating expenses Operating Income (Loss) Income from operations Nonoperating Income (Expense) [Abstract] Other income and (expenses): Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments Realized losses on short-term investments Realized losses on short-term investments Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Gain on disposal of equipment Gain on disposal of equipment Interest Income, Other Interest income Interest Expense Interest expense Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest Income before taxes Income Tax Expense (Benefit) Provision for income taxes Net Income (Loss) Attributable to Parent Net income Net income Net Income (Loss) Available to Common Stockholders, Basic Net income attributable to common stockholders, basic and diluted Net income attributable to common stockholders - basic Earnings Per Share, Basic and Diluted [Abstract] Net income per share attributable to common stockholders, basic and diluted: Earnings Per Share, Basic Basic net income per share (in dollars per share) Net income per share attributable to common stockholders - basic Earnings Per Share, Diluted Diluted net income per share (in dollars per share) Net income per share attributable to common stockholders-diluted Weighted Average Number of Shares Outstanding, Basic [Abstract] Weighted average shares of common stock outstanding: Weighted Average Number of Shares Outstanding, Basic Basic (in shares) Weighted average shares used in computing net income per share attributable to common stockholders - basic Weighted Average Number of Shares Outstanding, Diluted Diluted (in shares) Weighted average shares used in computing diluted net income per share attributable to common stockholders - diluted Income Statement Compensation Items [Abstract] Includes stock-based compensation expense as follows: Allocated Share-based Compensation Expense Total stock-based compensation expense CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Other comprehensive income: Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax Realized losses on short-term investments reclassified from accumulated other comprehensive income, net of tax of $1 Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax Net change in unrealized gains and (losses) on available-for-sale investments, net of tax of $560 Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive income Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax Realized losses on short-term investments reclassified from accumulated other comprehensive income, tax Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Tax Net change in unrealized gains and (losses) on available-for-sale investments, tax CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Cash flows from operating activities: Adjustments to reconcile net income to net cash provided by operating activities: Adjustments to reconcile net income to net cash provided by operating activities: Share-based Compensation Stock-based compensation expense Depreciation Depreciation Amortization of Intangible Assets Amortization of intangibles Accretion (Amortization) of Discounts and Premiums, Investments Amortization of premiums on short-term investments Represents tax payments for equity award issuances. Payments of Tax For Equity Award Issuances Tax payments for equity award issuances Deferred Income Tax Expense (Benefit) Deferred income taxes Excess Tax Benefit from Share-based Compensation, Operating Activities Excess tax benefits from share-based compensation Gain (Loss) on Disposition of Other Assets Loss on disposal of long-lived assets Increase (Decrease) in Operating Capital [Abstract] Changes in assets and liabilities: Increase (Decrease) in Accounts Receivable Accounts receivable Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Increase (Decrease) in Income Taxes Receivable Income taxes receivable Increase (Decrease) in Other Operating Assets Other assets Increase (Decrease) in Accounts Payable Accounts payable Increase (Decrease) in Employee Related Liabilities Accrued compensation Increase (Decrease) in Other Current Liabilities Other liabilities Amount of increase (decrease) of the deferred rent credit and the incentive from the lessor. Increase (Decrease) in Deferred Rent Credit and Incentive from Lessor Deferred rent Increase (Decrease) in Deferred Revenue Deferred revenue Increase (Decrease) in Income Taxes Payable Income taxes payable Net Cash Provided by (Used in) Operating Activities, Continuing Operations Net cash provided by operating activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Cash flows from investing activities: Payments to Acquire Short-term Investments Purchases of short-term investments Proceeds from Sale, Maturity and Collection of Short-term Investments Sales and maturities of short-term investments Payments to Acquire Property, Plant, and Equipment Purchases of property and equipment The cash outflow associated with the development, modification or acquisition of software programs or applications for internal use and to be sold that qualify for capitalization. Payments for Software for Internal Use and to be Sold Investment in capitalized software Net Cash Provided by (Used in) Investing Activities, Continuing Operations Net cash used in investing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Cash flows from financing activities: Proceeds from Issuance Initial Public Offering Proceeds from issuance of common stock, net of underwriters' discount Proceeds from Sale of Treasury Stock Proceeds from issuance of treasury stock, net of underwriters' discount Payments of Stock Issuance Costs Payment of offering costs Repayments of Long-term Lines of Credit Repayment of credit facility borrowings Proceeds from Stock Options Exercised Proceeds from exercise of stock options Repayments of Long-term Capital Lease Obligations Capital lease obligations paid Represents tax for equity award issuances. Tax For Equity Award Issuances Tax payments for equity award issuances Excess Tax Benefit from Share-based Compensation, Financing Activities Excess tax benefits from share-based compensation Net Cash Provided by (Used in) Financing Activities, Continuing Operations Net cash provided by financing activities Cash and Cash Equivalents, Period Increase (Decrease) Increase in cash and cash equivalents Supplemental Cash Flow Information [Abstract] Supplemental cash flow disclosure: Income Taxes Paid, Net Cash paid during the period for: Income taxes, net of refunds Interest Paid Cash paid during the period for: Interest Noncash Investing and Financing Items [Abstract] Noncash investing activities: Capital Expenditures Incurred but Not yet Paid Accounts payable for purchases of and investment in property, equipment and capitalized software Future cash outflow to pay for compensation for investment in capitalized software. Capitalized Software, Accrued Compensation Accrued compensation for investment in capitalized software Represents the amount of offering costs that were incurred during a noncash or partial noncash transaction. Offering Costs Incurred But Not Paid Offering costs not yet paid BASIS OF PRESENTATION Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] BASIS OF PRESENTATION NET INCOME PER SHARE Earnings Per Share [Text Block] NET INCOME PER SHARE SHORT-TERM INVESTMENTS Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] SHORT-TERM INVESTMENTS FAIR VALUE MEASUREMENTS Fair Value Disclosures [Text Block] FAIR VALUE MEASUREMENTS COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] COMMITMENTS AND CONTINGENCIES Basis of Accounting, Policy [Policy Text Block] Basis of Presentation New Accounting Pronouncements, Policy [Policy Text Block] Recently Issued Accounting Standards Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of numerators and denominators of the basic and diluted EPS Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of antidilutive securities excluded from computation of earnings per share Available-for-sale Securities [Table Text Block] Schedule of short-term investments Investments Classified by Contractual Maturity Date [Table Text Block] Summary of estimated fair value of short-term investments, designated as available-for-sale and classified by the contractual maturity Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value [Table Text Block] Schedule of fair values and gross unrealized losses of available-for-sale securities aggregated by investment category Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule of fair value hierarchy for financial assets and liabilities measured at fair value on a recurring basis Earnings Per Share, Basic. Earnings per share - basic Undistributed Earnings (Loss) Allocated to Participating Securities, Basic Undistributed earnings allocated to participating securities Earnings Per Share, Diluted. Earnings per share - diluted Net Income (Loss) Available to Common Stockholders, Diluted Net income attributable to common stockholders - diluted Weighted Average Number Diluted Shares Outstanding Adjustment Effect of dilutive securities Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Earnings Per Share, Diluted, Other Disclosures [Abstract] NET INCOME PER SHARE Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Awards excluded from the computation of diluted net income per share because their inclusion would have been anti-dilutive Schedule of Available-for-sale Securities [Table] Schedule of Available-for-sale Securities [Line Items] Available-for-sale Securities, Amortized Cost Basis [Abstract] Available-for-sale securities: Available-for-sale Securities, Amortized Cost Basis Amortized Cost Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax Gross Unrealized Gains Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax Gross Unrealized Losses Fair value of available-for-sale debt and certificate of deposit securities maturing in the next rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. Available-for-sale Securities, Debt and Certificate of Deposit Maturities, Next Rolling Twelve Months, Fair Value Due in one year or less Fair value of available-for-sale debt and certificate of deposit securities maturing after the twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. Available-for-sale Securities, Debt and Certificate of Deposit Maturities, Rolling Year After Year One, Fair Value Due after one year through three years Other than Temporary Impairment Losses, Investments, Available-for-sale Securities Other-than-temporary impairments Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value [Abstract] Fair Values and Gross Unrealized Losses of Available-for-sale Securities in a Gross Loss Position for Less than Twelve Months Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value Estimated Fair Value Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Aggregate Loss Gross Unrealized Losses Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Assets, Fair Value Disclosure [Abstract] Cash Equivalents: Cash and Cash Equivalents, Fair Value Disclosure Cash equivalents Available-for-sale Securities, Current [Abstract] Short-term investments: EX-101.PRE 10 inov-20160331_pre.xml EX-101.PRE EX-101.DEF 11 inov-20160331_def.xml EX-101.DEF XML 12 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Mar. 31, 2016	Apr. 30, 2016
Entity Registrant Name	Inovalon Holdings, Inc.
Entity Central Index Key	0001619954
Document Type	10-Q
Document Period End Date	Mar. 31, 2016
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q1
Class A Common
Entity Common Stock, Shares Outstanding		66,905,308
Class B Common
Entity Common Stock, Shares Outstanding		85,437,106

XML 13 R2.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Current assets:
Cash and cash equivalents	$ 126,885	$ 114,034
Short-term investments	611,598	614,130
Accounts receivable (net of allowances of $1,320 and $1,022 at March 31, 2016 and December 31, 2015, respectively)	73,177	81,305
Prepaid expenses and other current assets	21,217	16,162
Income tax receivable	17,251	18,377
Total current assets	850,128	844,008
Noncurrent assets:
Property, equipment and capitalized software, net	65,278	65,031
Goodwill	137,733	137,733
Intangible assets, net	60,028	61,855
Other assets	3,940	4,250
Total assets	1,117,107	1,112,877
Current liabilities:
Accounts payable	17,716	21,136
Accrued compensation	10,281	13,538
Other current liabilities	14,168	11,444
Deferred revenue	7,044	5,507
Deferred rent	843	797
Credit facilities	18,750	15,000
Capital lease obligation	109	109
Total current liabilities	68,911	67,531
Noncurrent liabilities:
Credit facilities, less current portion	258,750	266,250
Capital lease obligation, less current portion	309	296
Deferred rent	2,251	2,446
Deferred income taxes	36,275	37,198
Total liabilities	$ 366,496	$ 373,721
Commitments and contingencies (Note 5)
Stockholders' equity:
Common stock
Preferred stock, $0.0001 par value, 100,000,000 shares authorized, zero shares issued and outstanding at March 31, 2016 and December 31, 2015, respectively
Additional paid-in-capital	$ 499,899	$ 493,197
Retained earnings	249,905	247,540
Other comprehensive loss (loss)	806	(1,582)
Total stockholders' equity	750,611	739,156
Total liabilities and stockholders' equity	$ 1,117,107	$ 1,112,877
Class A Common
Stockholders' equity:
Common stock
Class B Common
Stockholders' equity:
Common stock	$ 1	$ 1

XML 14 R3.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Accounts receivable, allowances
Accounts receivable, allowances (in dollars)	$ 1,320	$ 1,022
Common stock
Common stock, par value (in dollars per share)	$ 0.000005	$ 0.000005
Common stock, authorized shares	900,000,000	900,000,000
Common stock, issued shares	0	0
Common stock, outstanding shares	0	0
Preferred stock
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, Authorized shares	100,000,000	100,000,000
Preferred stock, issued shares	0	0
Preferred stock, outstanding shares	0	0
Class A Common
Common stock
Common stock, par value (in dollars per share)	$ 0.000005	$ 0.000005
Common stock, authorized shares	750,000,000	750,000,000
Common stock, issued shares	66,129,038	53,482,669
Common stock, outstanding shares	66,129,038	53,482,669
Class B Common
Common stock
Common stock, par value (in dollars per share)	$ 0.000005	$ 0.000005
Common stock, authorized shares	150,000,000	150,000,000
Common stock, issued shares	86,235,350	98,230,363
Common stock, outstanding shares	86,235,350	98,230,363

XML 15 R4.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Thousands

3 Months Ended

Mar. 31, 2016

Mar. 31, 2015

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

Revenue

$ 102,657

$ 93,633

Expenses:

Cost of revenue

^[1]

41,923

31,851

Sales and marketing

^[1]

6,559

1,850

Research and development

^[1]

5,932

5,411

General and administrative

^[1]

36,552

24,258

Depreciation and amortization

8,394

4,915

Total operating expenses

99,360

68,285

Income from operations

3,297

25,348

Other income and (expenses):

Realized losses on short-term investments

(4)

Gain on disposal of equipment

534

Interest income

1,442

Interest expense

(1,259)

(1,103)

Income before taxes

4,010

24,253

Provision for income taxes

1,645

10,494

Net income

2,365

13,759

Net income attributable to common stockholders, basic and diluted

$ 2,356

$ 13,759

Net income per share attributable to common stockholders, basic and diluted:

Basic net income per share (in dollars per share)

$ 0.02

$ 0.10

Diluted net income per share (in dollars per share)

$ 0.02

$ 0.10

Weighted average shares of common stock outstanding:

Basic (in shares)

151,282

135,331

Diluted (in shares)

152,355

138,902

[1]

XML 16 R5.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Parenthetical) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Includes stock-based compensation expense as follows:
Total stock-based compensation expense	$ 2,092	$ 1,772
Cost of revenue
Includes stock-based compensation expense as follows:
Total stock-based compensation expense	119	28
Sales and marketing
Includes stock-based compensation expense as follows:
Total stock-based compensation expense	154	15
Research and development
Includes stock-based compensation expense as follows:
Total stock-based compensation expense	242	362
General and administrative
Includes stock-based compensation expense as follows:
Total stock-based compensation expense	$ 1,577	$ 1,367

XML 17 R6.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
Net income	$ 2,365	$ 13,759
Other comprehensive income:
Realized losses on short-term investments reclassified from accumulated other comprehensive income, net of tax of $1	3
Net change in unrealized gains and (losses) on available-for-sale investments, net of tax of $560	2,385
Comprehensive income	$ 4,753	$ 13,759

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

XML 18 R7.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) $ in Thousands	3 Months Ended
	Mar. 31, 2016 USD ($)
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
Realized losses on short-term investments reclassified from accumulated other comprehensive income, tax	$ 1
Net change in unrealized gains and (losses) on available-for-sale investments, tax	$ 560

XML 19 R8.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Cash flows from operating activities:
Net income	$ 2,365	$ 13,759
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation expense	2,092	1,772
Depreciation	6,567	4,373
Amortization of intangibles	1,827	542
Amortization of premiums on short-term investments	871
Realized losses on short-term investments	4
Tax payments for equity award issuances	88
Deferred income taxes	(1,252)	(493)
Excess tax benefits from share-based compensation	(911)
Loss on disposal of long-lived assets		4
Gain on disposal of equipment	(534)
Changes in assets and liabilities:
Accounts receivable	8,128	(21,703)
Prepaid expenses and other current assets	(5,054)	277
Income taxes receivable	2,037	6,797
Other assets	78	(171)
Accounts payable	(2,194)	(1,685)
Accrued compensation	(3,877)	(6,368)
Other liabilities	2,676	655
Deferred rent	(149)	(109)
Deferred revenue	1,537	613
Income taxes payable		2,554
Net cash provided by operating activities	14,299	817
Cash flows from investing activities:
Purchases of short-term investments	(80,065)
Sales and maturities of short-term investments	84,671
Purchases of property and equipment	(4,053)	(1,338)
Investment in capitalized software	(2,790)	(5,158)
Net cash used in investing activities	(2,237)	(6,496)
Cash flows from financing activities:
Proceeds from issuance of common stock, net of underwriters' discount		362,082
Proceeds from issuance of treasury stock, net of underwriters' discount		282,172
Payment of offering costs		(3,002)
Repayment of credit facility borrowings	(3,750)	(5,000)
Proceeds from exercise of stock options	3,841
Capital lease obligations paid	(31)	(26)
Tax payments for equity award issuances	(182)
Excess tax benefits from share-based compensation	911
Net cash provided by financing activities	789	636,226
Increase in cash and cash equivalents	12,851	630,547
Cash and cash equivalents, beginning of period	114,034	162,567
Cash and cash equivalents, end of period	126,885	793,114
Supplemental cash flow disclosure:
Cash paid during the period for: Income taxes, net of refunds	861	1,583
Cash paid during the period for: Interest	1,195	1,076
Noncash investing activities:
Accounts payable for purchases of and investment in property, equipment and capitalized software	933	1,557
Accrued compensation for investment in capitalized software	$ 53	464
Offering costs not yet paid		$ 2,180

XML 20 R9.htm IDEA: XBRL DOCUMENT

BASIS OF PRESENTATION	3 Months Ended
BASIS OF PRESENTATION	Mar. 31, 2016
BASIS OF PRESENTATION
BASIS OF PRESENTATION	1. BASIS OF PRESENTATION The accompanying unaudited condensed consolidated financial statements have been prepared by Inovalon Holdings, Inc. (the "Company") in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial reporting and as required by Rule 10-01 of Regulation S-X. Accordingly, the unaudited condensed consolidated financial statements may not include all of the information and notes required by GAAP for audited financial statements. In the opinion of the Company's management, the accompanying unaudited condensed consolidated financial statements contain all adjustments, consisting of items of a normal and recurring nature, necessary to present fairly the Company's financial position as of March 31, 2016 and the results of operations, comprehensive income and cash flows for the three month periods ended March 31, 2016 and 2015. The results of operations for the three month period ended March 31, 2016 are not necessarily indicative of the results to be expected for the full year. The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities, disclosures of contingent assets and liabilities as of the date of the financial statements, and the reported amounts of revenue and expenses during the reported period. Actual results could differ from management's estimates, and such differences could be material to the Company's consolidated financial position and results of operations. The accompanying condensed consolidated financial statements include the accounts of Inovalon Holdings, Inc. and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The Company's management considers events or transactions that occur after the balance sheet date but before the financial statements are issued to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure. Subsequent events have been evaluated through the date of issuance of these financial statements. Recently Issued Accounting Standards There have been no developments to recently issued accounting standards, including the expected dates of adoption and estimated effects on the Company's consolidated financial statements and note disclosures, from those disclosed in the Company's 2015 Annual Report on Form 10-K, except for the following: In February 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update No. 2016-02, Leases (Topic 842) ("ASU 2016-02"). ASU 2016-02 requires the identification of arrangements that should be accounted for as leases by lessees. This guidance is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. In general, for lease arrangements exceeding a twelve month term, these arrangements will be recognized as assets and liabilities on the balance sheet of the lessee. Under ASU 2016-02, a right-of-use asset and lease obligation will be recorded for all leases, whether operating or financing, while the income statement will reflect lease expense for operating leases and amortization/interest expense for financing leases. The balance sheet amount recorded for existing leases at the date of adoption of ASU 2016-02 will be calculated using the applicable incremental borrowing rate at the date of adoption. In addition, ASU 2016-02 requires the use of the modified retrospective method, which will require adjustment to all comparative periods presented in the consolidated financial statements. The Company is currently assessing the impact that adopting this new accounting standard will have on its consolidated financial statements and note disclosures. In March 2016, the FASB issued Accounting Standards Update No. 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net) ("ASU 2016-08"). This guidance is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017. ASU 2016-08 clarifies the implementation guidance on principal versus agent considerations. The guidance includes indicators to assist an entity in determining whether it controls a specified good or service before it is transferred to the customers. The Company is currently assessing the impact that adopting this new accounting standard will have on its consolidated financial statements and note disclosures. In March 2016, the FASB issued Accounting Standards Update No. 2016-09, Compensation—Stock Compensation (Topic 718) ("ASU 2016-09"). This guidance is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016, with early adoption permitted. ASU 2016-09 identifies areas for simplification involving several aspects of accounting for share-based payment transactions, including income tax consequences, classification of awards as either equity or liabilities, an option to recognize gross stock compensation expense with actual forfeitures recognized as they occur, as well as certain classifications on the statement of cash flows. The Company is currently assessing the impact that adopting this new accounting standard will have on its consolidated financial statements and note disclosures. The adoption of this new accounting standard could have a material impact on the Company's consolidated financial statements.

XML 21 R10.htm IDEA: XBRL DOCUMENT

NET INCOME PER SHARE

3 Months Ended

Mar. 31, 2016

NET INCOME PER SHARE

NET INCOME PER SHARE

2. NET INCOME PER SHARE(in thousands, except per share amounts)

The following table reconciles the weighted average shares outstanding for basic and diluted EPS for the periods indicated:

	Three Months Ended March 31,
	2016			2015
Basic
Numerator:
Net income	$	2,365		$	13,759
Undistributed earnings allocated to participating securities		(9	)		—

Net income attributable to common stockholders—basic	$	2,356		$	13,759


Denominator:
Weighted average shares used in computing net income per share attributable to common stockholders—basic		151,282			135,331

Net income per share attributable to common stockholders—basic	$	0.02		$	0.10


Diluted
Numerator:
Net income attributable to common stockholders—diluted	$	2,356		$	13,759


Denominator:
Number of shares used for basic EPS computation		151,282			135,331
Effect of dilutive securities		1,073			3,571

Weighted average shares used in computing net income per share attributable to common stockholders—diluted		152,355			138,902

Net income per share attributable to common stockholders—diluted	$	0.02		$	0.10

	Three Months Ended March 31,
	2016		2015
Awards excluded from the computation of diluted net income per share because their inclusion would have been anti-dilutive		110		23

XML 22 R11.htm IDEA: XBRL DOCUMENT

SHORT-TERM INVESTMENTS

3 Months Ended

Mar. 31, 2016

SHORT-TERM INVESTMENTS

SHORT-TERM INVESTMENTS

3. SHORT-TERM INVESTMENTS(in thousands)

As of March 31, 2016, short-term investments consisted of the following:

	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Estimated Fair Value
Available-for-sale securities:
Corporate notes and bonds	$	407,461	$	620	$	(528	)	$	407,553
U.S. agency obligations		97,562		43		(13	)		97,592
U.S. treasury securities		70,291		76		(27	)		70,340
Commercial paper		29,798		66		(6	)		29,858
Certificates of deposit		6,251		4		—			6,255

Total available-for-sale securities	$	611,363	$	809	$	(574	)	$	611,598

As of December 31, 2015, short-term investments consisted of the following:

	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Estimated Fair Value
Available-for-sale securities:
Corporate notes and bonds	$	390,185	$	12	$	(2,321	)	$	387,876
U.S. agency obligations		121,521		11		(203	)		121,329
U.S. treasury securities		60,362		2		(179	)		60,185
Commercial paper		36,849		—		(28	)		36,821
Certificates of deposit		7,928		—		(9	)		7,919

Total available-for-sale securities	$	616,845	$	25	$	(2,740	)	$	614,130

	March 31, 2016		December 31, 2015
Due in one year or less	$	217,876	$	206,679
Due after one year through three years		393,722		407,451

Total	$	611,598	$	614,130

	Estimated Fair Value		Gross Unrealized Losses
Corporate notes and bonds	$	257,125	$	(528	)
U.S. agency obligations		30,585		(13	)
U.S. treasury securities		50,977		(27	)
Commercial paper		12,475		(6	)
Certificates of deposit		961		—

	$	352,123	$	(574	)

- Definition

The entire disclosure for investments in certain debt and equity securities.

+ References + Details

XML 23 R12.htm IDEA: XBRL DOCUMENT

FAIR VALUE MEASUREMENTS

3 Months Ended

Mar. 31, 2016

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS

4. FAIR VALUE MEASUREMENTS (in thousands)

The following table presents the fair value hierarchy for financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2016:

	Level 1		Level 2		Level 3			Total
Cash Equivalents:
Money market funds	$	19,298	$	—	$	—		$	19,298
Short-term investments:
Corporate notes and bonds		—		407,553		—			407,553
U.S. agency obligations		—		97,592		—			97,592
U.S. treasury securities		—		70,340		—			70,340
Commercial paper		—		29,858		—			29,858
Certificates of deposit		—		6,255		—			6,255
Other Current Liabilities:
Contingent consideration		—		—		(2,300	)		(2,300	)

Total	$	19,298	$	611,598	$	(2,300	)	$	628,596

The following table presents the fair value hierarchy for financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2015:

	Level 1		Level 2		Level 3			Total
Cash Equivalents:
Money market funds	$	2,521	$	—	$	—		$	2,521
Short-term investments:
Corporate notes and bonds		—		387,876		—			387,876
U.S. agency obligations		—		121,329		—			121,329
U.S. treasury securities		—		60,185		—			60,185
Commercial paper		—		36,821		—			36,821
Certificates of deposit		—		7,919		—			7,919
Other Current Liabilities:
Contingent consideration		—		—		(2,300	)		(2,300	)

Total	$	2,521	$	614,130	$	(2,300	)	$	614,351

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 24 R13.htm IDEA: XBRL DOCUMENT

COMMITMENTS AND CONTINGENCIES	3 Months Ended
COMMITMENTS AND CONTINGENCIES	Mar. 31, 2016
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES	5. COMMITMENTS AND CONTINGENCIES (in thousands) Litigation—From time to time the Company is involved in various litigation matters arising out of the normal course of business. The Company consults with legal counsel on those issues related to litigation and seeks input from other experts and advisors with respect to such matters. Estimating the probable losses or a range of probable losses resulting from litigation, government actions and other legal proceedings is inherently difficult and requires an extensive degree of judgment, particularly where the matters involve indeterminate claims for monetary damages, may involve discretionary amounts, present novel legal theories, are in the early stages of the proceedings, or are subject to appeal. Whether any losses, damages or remedies ultimately resulting from such matters could reasonably have a material effect on the Company's business, financial condition, results of operations, or cash flows will depend on a number of variables, including, for example, the timing and amount of such losses or damages (if any) and the structure and type of any such remedies. The Company's management does not presently expect any litigation matters to have a material adverse impact on the condensed consolidated financial statements of the Company.

XML 25 R14.htm IDEA: XBRL DOCUMENT

BASIS OF PRESENTATION (Policies)	3 Months Ended
BASIS OF PRESENTATION (Policies)	Mar. 31, 2016
BASIS OF PRESENTATION
Basis of Presentation	BASIS OF PRESENTATION The accompanying unaudited condensed consolidated financial statements have been prepared by Inovalon Holdings, Inc. (the "Company") in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial reporting and as required by Rule 10-01 of Regulation S-X. Accordingly, the unaudited condensed consolidated financial statements may not include all of the information and notes required by GAAP for audited financial statements. In the opinion of the Company's management, the accompanying unaudited condensed consolidated financial statements contain all adjustments, consisting of items of a normal and recurring nature, necessary to present fairly the Company's financial position as of March 31, 2016 and the results of operations, comprehensive income and cash flows for the three month periods ended March 31, 2016 and 2015. The results of operations for the three month period ended March 31, 2016 are not necessarily indicative of the results to be expected for the full year. The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities, disclosures of contingent assets and liabilities as of the date of the financial statements, and the reported amounts of revenue and expenses during the reported period. Actual results could differ from management's estimates, and such differences could be material to the Company's consolidated financial position and results of operations. The accompanying condensed consolidated financial statements include the accounts of Inovalon Holdings, Inc. and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The Company's management considers events or transactions that occur after the balance sheet date but before the financial statements are issued to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure. Subsequent events have been evaluated through the date of issuance of these financial statements.
Recently Issued Accounting Standards	Recently Issued Accounting Standards There have been no developments to recently issued accounting standards, including the expected dates of adoption and estimated effects on the Company's consolidated financial statements and note disclosures, from those disclosed in the Company's 2015 Annual Report on Form 10-K, except for the following: In February 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update No. 2016-02, Leases (Topic 842) ("ASU 2016-02"). ASU 2016-02 requires the identification of arrangements that should be accounted for as leases by lessees. This guidance is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. In general, for lease arrangements exceeding a twelve month term, these arrangements will be recognized as assets and liabilities on the balance sheet of the lessee. Under ASU 2016-02, a right-of-use asset and lease obligation will be recorded for all leases, whether operating or financing, while the income statement will reflect lease expense for operating leases and amortization/interest expense for financing leases. The balance sheet amount recorded for existing leases at the date of adoption of ASU 2016-02 will be calculated using the applicable incremental borrowing rate at the date of adoption. In addition, ASU 2016-02 requires the use of the modified retrospective method, which will require adjustment to all comparative periods presented in the consolidated financial statements. The Company is currently assessing the impact that adopting this new accounting standard will have on its consolidated financial statements and note disclosures. In March 2016, the FASB issued Accounting Standards Update No. 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net) ("ASU 2016-08"). This guidance is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017. ASU 2016-08 clarifies the implementation guidance on principal versus agent considerations. The guidance includes indicators to assist an entity in determining whether it controls a specified good or service before it is transferred to the customers. The Company is currently assessing the impact that adopting this new accounting standard will have on its consolidated financial statements and note disclosures. In March 2016, the FASB issued Accounting Standards Update No. 2016-09, Compensation—Stock Compensation (Topic 718) ("ASU 2016-09"). This guidance is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016, with early adoption permitted. ASU 2016-09 identifies areas for simplification involving several aspects of accounting for share-based payment transactions, including income tax consequences, classification of awards as either equity or liabilities, an option to recognize gross stock compensation expense with actual forfeitures recognized as they occur, as well as certain classifications on the statement of cash flows. The Company is currently assessing the impact that adopting this new accounting standard will have on its consolidated financial statements and note disclosures. The adoption of this new accounting standard could have a material impact on the Company's consolidated financial statements.

XML 26 R15.htm IDEA: XBRL DOCUMENT

NET INCOME PER SHARE (Tables)

3 Months Ended

Mar. 31, 2016

NET INCOME PER SHARE

Schedule of numerators and denominators of the basic and diluted EPS

	Three Months Ended March 31,
	2016			2015
Basic
Numerator:
Net income	$	2,365		$	13,759
Undistributed earnings allocated to participating securities		(9	)		—

Net income attributable to common stockholders—basic	$	2,356		$	13,759


Denominator:
Weighted average shares used in computing net income per share attributable to common stockholders—basic		151,282			135,331

Net income per share attributable to common stockholders—basic	$	0.02		$	0.10


Diluted
Numerator:
Net income attributable to common stockholders—diluted	$	2,356		$	13,759


Denominator:
Number of shares used for basic EPS computation		151,282			135,331
Effect of dilutive securities		1,073			3,571

Weighted average shares used in computing net income per share attributable to common stockholders—diluted		152,355			138,902

Net income per share attributable to common stockholders—diluted	$	0.02		$	0.10

Schedule of antidilutive securities excluded from computation of earnings per share

	Three Months Ended March 31,
	2016		2015
Awards excluded from the computation of diluted net income per share because their inclusion would have been anti-dilutive		110		23

XML 27 R16.htm IDEA: XBRL DOCUMENT

SHORT-TERM INVESTMENTS (Tables)

3 Months Ended

Mar. 31, 2016

SHORT-TERM INVESTMENTS

Schedule of short-term investments

As of March 31, 2016, short-term investments consisted of the following:

	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Estimated Fair Value
Available-for-sale securities:
Corporate notes and bonds	$	407,461	$	620	$	(528	)	$	407,553
U.S. agency obligations		97,562		43		(13	)		97,592
U.S. treasury securities		70,291		76		(27	)		70,340
Commercial paper		29,798		66		(6	)		29,858
Certificates of deposit		6,251		4		—			6,255

Total available-for-sale securities	$	611,363	$	809	$	(574	)	$	611,598

As of December 31, 2015, short-term investments consisted of the following:

	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Estimated Fair Value
Available-for-sale securities:
Corporate notes and bonds	$	390,185	$	12	$	(2,321	)	$	387,876
U.S. agency obligations		121,521		11		(203	)		121,329
U.S. treasury securities		60,362		2		(179	)		60,185
Commercial paper		36,849		—		(28	)		36,821
Certificates of deposit		7,928		—		(9	)		7,919

Total available-for-sale securities	$	616,845	$	25	$	(2,740	)	$	614,130

Summary of estimated fair value of short-term investments, designated as available-for-sale and classified by the contractual maturity

	March 31, 2016		December 31, 2015
Due in one year or less	$	217,876	$	206,679
Due after one year through three years		393,722		407,451

Total	$	611,598	$	614,130

Schedule of fair values and gross unrealized losses of available-for-sale securities aggregated by investment category

	Estimated Fair Value		Gross Unrealized Losses
Corporate notes and bonds	$	257,125	$	(528	)
U.S. agency obligations		30,585		(13	)
U.S. treasury securities		50,977		(27	)
Commercial paper		12,475		(6	)
Certificates of deposit		961		—

	$	352,123	$	(574	)

- Definition

Tabular disclosure of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.

+ References + Details

XML 28 R17.htm IDEA: XBRL DOCUMENT

FAIR VALUE MEASUREMENTS (Tables)

3 Months Ended

Mar. 31, 2016

FAIR VALUE MEASUREMENTS

Schedule of fair value hierarchy for financial assets and liabilities measured at fair value on a recurring basis

The following table presents the fair value hierarchy for financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2016:

	Level 1		Level 2		Level 3			Total
Cash Equivalents:
Money market funds	$	19,298	$	—	$	—		$	19,298
Short-term investments:
Corporate notes and bonds		—		407,553		—			407,553
U.S. agency obligations		—		97,592		—			97,592
U.S. treasury securities		—		70,340		—			70,340
Commercial paper		—		29,858		—			29,858
Certificates of deposit		—		6,255		—			6,255
Other Current Liabilities:
Contingent consideration		—		—		(2,300	)		(2,300	)

Total	$	19,298	$	611,598	$	(2,300	)	$	628,596

The following table presents the fair value hierarchy for financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2015:

	Level 1		Level 2		Level 3			Total
Cash Equivalents:
Money market funds	$	2,521	$	—	$	—		$	2,521
Short-term investments:
Corporate notes and bonds		—		387,876		—			387,876
U.S. agency obligations		—		121,329		—			121,329
U.S. treasury securities		—		60,185		—			60,185
Commercial paper		—		36,821		—			36,821
Certificates of deposit		—		7,919		—			7,919
Other Current Liabilities:
Contingent consideration		—		—		(2,300	)		(2,300	)

Total	$	2,521	$	614,130	$	(2,300	)	$	614,351

XML 29 R18.htm IDEA: XBRL DOCUMENT

NET INCOME PER SHARE - Tabular Disclosure (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Earnings per share - basic
Net income	$ 2,365	$ 13,759
Undistributed earnings allocated to participating securities	(9)
Net income attributable to common stockholders - basic	$ 2,356	$ 13,759
Weighted average shares used in computing net income per share attributable to common stockholders - basic	151,282	135,331
Net income per share attributable to common stockholders - basic	$ 0.02	$ 0.10
Earnings per share - diluted
Net income attributable to common stockholders - diluted	$ 2,356	$ 13,759
Weighted average shares used in computing net income per share attributable to common stockholders - basic	151,282	135,331
Effect of dilutive securities	1,073	3,571
Weighted average shares used in computing diluted net income per share attributable to common stockholders - diluted	152,355	138,902
Net income per share attributable to common stockholders-diluted	$ 0.02	$ 0.10

XML 30 R19.htm IDEA: XBRL DOCUMENT

NET INCOME PER SHARE - Anti-dilutive Securities (Details) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Equity awards
NET INCOME PER SHARE
Awards excluded from the computation of diluted net income per share because their inclusion would have been anti-dilutive	110	23

XML 31 R20.htm IDEA: XBRL DOCUMENT

SHORT-TERM INVESTMENTS - Available-for-sale Securities (Details) - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Available-for-sale securities:
Amortized Cost	$ 611,363	$ 616,845
Gross Unrealized Gains	809	25
Gross Unrealized Losses	(574)	(2,740)
Estimated Fair Value	611,598	614,130
Corporate notes and bonds
Available-for-sale securities:
Amortized Cost	407,461	390,185
Gross Unrealized Gains	620	12
Gross Unrealized Losses	(528)	(2,321)
Estimated Fair Value	407,553	387,876
U.S. agency obligations
Available-for-sale securities:
Amortized Cost	97,562	121,521
Gross Unrealized Gains	43	11
Gross Unrealized Losses	(13)	(203)
Estimated Fair Value	97,592	121,329
U.S. treasury securities
Available-for-sale securities:
Amortized Cost	70,291	60,362
Gross Unrealized Gains	76	2
Gross Unrealized Losses	(27)	(179)
Estimated Fair Value	70,340	60,185
Commercial paper
Available-for-sale securities:
Amortized Cost	29,798	36,849
Gross Unrealized Gains	66
Gross Unrealized Losses	(6)	(28)
Estimated Fair Value	29,858	36,821
Certificates of deposit
Available-for-sale securities:
Amortized Cost	6,251	7,928
Gross Unrealized Gains	4
Gross Unrealized Losses		(9)
Estimated Fair Value	$ 6,255	$ 7,919

XML 32 R21.htm IDEA: XBRL DOCUMENT

SHORT-TERM INVESTMENTS - Estimated Fair Value by Contractual Maturity Date (Details) - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
SHORT-TERM INVESTMENTS
Due in one year or less	$ 217,876	$ 206,679
Due after one year through three years	393,722	407,451
Total	$ 611,598	$ 614,130

XML 33 R22.htm IDEA: XBRL DOCUMENT

SHORT-TERM INVESTMENTS - Other-than-temporary Impairments (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2016 USD ($)
SHORT-TERM INVESTMENTS
Other-than-temporary impairments	$ 0

XML 34 R23.htm IDEA: XBRL DOCUMENT

SHORT-TERM INVESTMENTS - Fair Values and Gross Unrealized Losses of Available-for-sale Securities in a Gross Loss Position for Less than Twelve Months (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2016 USD ($)
Fair Values and Gross Unrealized Losses of Available-for-sale Securities in a Gross Loss Position for Less than Twelve Months
Estimated Fair Value	$ 352,123
Gross Unrealized Losses	(574)
Corporate notes and bonds
Fair Values and Gross Unrealized Losses of Available-for-sale Securities in a Gross Loss Position for Less than Twelve Months
Estimated Fair Value	257,125
Gross Unrealized Losses	(528)
U.S. agency obligations
Fair Values and Gross Unrealized Losses of Available-for-sale Securities in a Gross Loss Position for Less than Twelve Months
Estimated Fair Value	30,585
Gross Unrealized Losses	(13)
Commercial paper
Fair Values and Gross Unrealized Losses of Available-for-sale Securities in a Gross Loss Position for Less than Twelve Months
Estimated Fair Value	12,475
Gross Unrealized Losses	(6)
Certificates of deposit
Fair Values and Gross Unrealized Losses of Available-for-sale Securities in a Gross Loss Position for Less than Twelve Months
Estimated Fair Value	$ 961

XML 35 R24.htm IDEA: XBRL DOCUMENT

FAIR VALUE MEASUREMENTS - Fair Value Hierarchy Table (Details) - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Short-term investments:
Short-term investments	$ 611,598	$ 614,130
Corporate notes and bonds
Short-term investments:
Short-term investments	407,553	387,876
U.S. agency obligations
Short-term investments:
Short-term investments	97,592	121,329
U.S. treasury securities
Short-term investments:
Short-term investments	70,340	60,185
Commercial paper
Short-term investments:
Short-term investments	29,858	36,821
Certificates of deposit
Short-term investments:
Short-term investments	6,255	7,919
Recurring
Total
Total	628,596	614,351
Recurring \| Money market funds
Cash Equivalents:
Cash equivalents	19,298	2,521
Recurring \| Level 1
Total
Total	19,298	2,521
Recurring \| Level 1 \| Money market funds
Cash Equivalents:
Cash equivalents	19,298	2,521
Recurring \| Level 2
Total
Total	611,598	614,130
Recurring \| Level 3
Total
Total	(2,300)	(2,300)
Recurring \| Contingent consideration
Other Current Liabilities:
Contingent consideration	(2,300)	(2,300)
Recurring \| Contingent consideration \| Level 3
Other Current Liabilities:
Contingent consideration	(2,300)	(2,300)
Recurring \| Corporate notes and bonds
Short-term investments:
Short-term investments	407,553	387,876
Recurring \| Corporate notes and bonds \| Level 2
Short-term investments:
Short-term investments	407,553	387,876
Recurring \| U.S. agency obligations
Short-term investments:
Short-term investments	97,592	121,329
Recurring \| U.S. agency obligations \| Level 2
Short-term investments:
Short-term investments	97,592	121,329
Recurring \| U.S. treasury securities
Short-term investments:
Short-term investments	70,340	60,185
Recurring \| U.S. treasury securities \| Level 2
Short-term investments:
Short-term investments	70,340	60,185
Recurring \| Commercial paper
Short-term investments:
Short-term investments	29,858	36,821
Recurring \| Commercial paper \| Level 2
Short-term investments:
Short-term investments	29,858	36,821
Recurring \| Certificates of deposit
Short-term investments:
Short-term investments	6,255	7,919
Recurring \| Certificates of deposit \| Level 2
Short-term investments:
Short-term investments	$ 6,255	$ 7,919

XML 36 R25.htm IDEA: XBRL DOCUMENT

FAIR VALUE MEASUREMENTS - Contingent Consideration (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2016 USD ($)
Contingent consideration \| General and administrative
FAIR VALUE MEASUREMENTS
Increase (decrease) in the fair value of contingent consideration	$ 0

EXCEL 37 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 38 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 39 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 41 FilingSummary.xml IDEA: XBRL DOCUMENT 3.4.0.3 html 72 146 1 true 18 0 false 3 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.inovalon.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.inovalon.com/role/StatementCondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 00105 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.inovalon.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME Sheet http://www.inovalon.com/role/StatementCondensedConsolidatedStatementsOfIncome CONDENSED CONSOLIDATED STATEMENTS OF INCOME Statements 4 false false R5.htm 00205 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Parenthetical) Sheet http://www.inovalon.com/role/StatementCondensedConsolidatedStatementsOfIncomeParenthetical CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Parenthetical) Statements 5 false false R6.htm 00300 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Sheet http://www.inovalon.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncome CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Statements 6 false false R7.htm 00305 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) Sheet http://www.inovalon.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeParenthetical CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) Statements 7 false false R8.htm 00400 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.inovalon.com/role/StatementCondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 8 false false R9.htm 10101 - Disclosure - BASIS OF PRESENTATION Sheet http://www.inovalon.com/role/DisclosureBasisOfPresentation BASIS OF PRESENTATION Notes 9 false false R10.htm 10201 - Disclosure - NET INCOME PER SHARE Sheet http://www.inovalon.com/role/DisclosureNetIncomePerShare NET INCOME PER SHARE Notes 10 false false R11.htm 10301 - Disclosure - SHORT-TERM INVESTMENTS Sheet http://www.inovalon.com/role/DisclosureShortTermInvestments SHORT-TERM INVESTMENTS Notes 11 false false R12.htm 10401 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://www.inovalon.com/role/DisclosureFairValueMeasurements FAIR VALUE MEASUREMENTS Notes 12 false false R13.htm 10501 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.inovalon.com/role/DisclosureCommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 13 false false R14.htm 20102 - Disclosure - BASIS OF PRESENTATION (Policies) Sheet http://www.inovalon.com/role/DisclosureBasisOfPresentationPolicies BASIS OF PRESENTATION (Policies) Policies 14 false false R15.htm 30203 - Disclosure - NET INCOME PER SHARE (Tables) Sheet http://www.inovalon.com/role/DisclosureNetIncomePerShareTables NET INCOME PER SHARE (Tables) Tables http://www.inovalon.com/role/DisclosureNetIncomePerShare 15 false false R16.htm 30303 - Disclosure - SHORT-TERM INVESTMENTS (Tables) Sheet http://www.inovalon.com/role/DisclosureShortTermInvestmentsTables SHORT-TERM INVESTMENTS (Tables) Tables http://www.inovalon.com/role/DisclosureShortTermInvestments 16 false false R17.htm 30403 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://www.inovalon.com/role/DisclosureFairValueMeasurementsTables FAIR VALUE MEASUREMENTS (Tables) Tables http://www.inovalon.com/role/DisclosureFairValueMeasurements 17 false false R18.htm 40201 - Disclosure - NET INCOME PER SHARE - Tabular Disclosure (Details) Sheet http://www.inovalon.com/role/DisclosureNetIncomePerShareTabularDisclosureDetails NET INCOME PER SHARE - Tabular Disclosure (Details) Details 18 false false R19.htm 40202 - Disclosure - NET INCOME PER SHARE - Anti-dilutive Securities (Details) Sheet http://www.inovalon.com/role/DisclosureNetIncomePerShareAntiDilutiveSecuritiesDetails NET INCOME PER SHARE - Anti-dilutive Securities (Details) Details 19 false false R20.htm 40301 - Disclosure - SHORT-TERM INVESTMENTS - Available-for-sale Securities (Details) Sheet http://www.inovalon.com/role/DisclosureShortTermInvestmentsAvailableForSaleSecuritiesDetails SHORT-TERM INVESTMENTS - Available-for-sale Securities (Details) Details 20 false false R21.htm 40302 - Disclosure - SHORT-TERM INVESTMENTS - Estimated Fair Value by Contractual Maturity Date (Details) Sheet http://www.inovalon.com/role/DisclosureShortTermInvestmentsEstimatedFairValueByContractualMaturityDateDetails SHORT-TERM INVESTMENTS - Estimated Fair Value by Contractual Maturity Date (Details) Details 21 false false R22.htm 40303 - Disclosure - SHORT-TERM INVESTMENTS - Other-than-temporary Impairments (Details) Sheet http://www.inovalon.com/role/DisclosureShortTermInvestmentsOtherThanTemporaryImpairmentsDetails SHORT-TERM INVESTMENTS - Other-than-temporary Impairments (Details) Details 22 false false R23.htm 40304 - Disclosure - SHORT-TERM INVESTMENTS - Fair Values and Gross Unrealized Losses of Available-for-sale Securities in a Gross Loss Position for Less than Twelve Months (Details) Sheet http://www.inovalon.com/role/DisclosureShortTermInvestmentsFairValuesAndGrossUnrealizedLossesOfAvailableForSaleSecuritiesInGrossLossPositionForLessThanTwelveMonthsDetails SHORT-TERM INVESTMENTS - Fair Values and Gross Unrealized Losses of Available-for-sale Securities in a Gross Loss Position for Less than Twelve Months (Details) Details 23 false false R24.htm 40401 - Disclosure - FAIR VALUE MEASUREMENTS - Fair Value Hierarchy Table (Details) Sheet http://www.inovalon.com/role/DisclosureFairValueMeasurementsFairValueHierarchyTableDetails FAIR VALUE MEASUREMENTS - Fair Value Hierarchy Table (Details) Details 24 false false R25.htm 40402 - Disclosure - FAIR VALUE MEASUREMENTS - Contingent Consideration (Details) Sheet http://www.inovalon.com/role/DisclosureFairValueMeasurementsContingentConsiderationDetails FAIR VALUE MEASUREMENTS - Contingent Consideration (Details) Details 25 false false All Reports Book All Reports inov-20160331.xml inov-20160331.xsd inov-20160331_cal.xml inov-20160331_def.xml inov-20160331_lab.xml inov-20160331_pre.xml true true ZIP 43 0001047469-16-012899-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001047469-16-012899-xbrl.zip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end